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The early arrest mutant ogre, isolated in the Tübingen screen, has a block in
cytokinesis (Kane et al., 1996). Here I use genetic and molecular techniques to
demonstrate that the ogre phenotype is caused by a lesion in the gene encoding
Racgap1. I performed fine mapping studies using microsatellite markers to a 0.15 cM
region containing the ogre locus. DNA sequence data revealed a nonsense mutation
in the Racgap1 gene of ogre mutants, and in situ hybridization experiments showed a
loss of racgap1 mRNA at later stages of development, likely by nonsense mediated
decay. This evidence supports the abolishment of Racgap1’s GTPase activating
(GAP) function which is required for the inactivation of RhoA, a necessary step for
the completion of cytokinesis. This failure in cytokinesis drastically affects some
neural, erythrocyte and podocyte populations resulting in cell death most likely by
apoptosis. Injection of wild-type racgap1 mRNA in ogre resulted in a partial rescue
of the morphological, neural, and cellular phenotypes. These data provide definitive
evidence that ogre is Racgap1 and indicate that just as in the fly, and the worm, GAP
function of Racgap1 is necessary for cytokinesis in zebrafish.
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CHAPTER I
INTRODUCTION
Background
The zebrafish mutant ogre was identified due to its arrest in early
embryogenesis (Kane et al., 1996). The mutant was found to have a block in
the cell cycle. The cell cycle is divided into two phases, interphase in which
the cell grows and mitosis, in which results in the cell divides. It is important
to study the cell cycle because cell division dictates embryonic growth and
morphogenesis.

Zebrafish Development
Embryogenesis in zebrafish has been extensively characterized. For
this thesis the nomenclature described by Kimmel et al. 1995 to be utilized
throughout. In zebrafish, embryogenesis is divided into developmental phases
termed cleavage, blastula, gastrula, segmentation, pharyngula, and the hatching
period. The work in this thesis is done within the first 35 hours of
development, at which time most cells are committed to a specific cell fate or
have already differentiated.
Cleavage Phase (0.7 - 2.2 hours).
The cleavage phase comprises cell cycles 2 through 7 resulting in
doublings to 2-, 4-, 8-, 16-, 32-, and 64-celled embryos. During the cleavage
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phase, cell division is synchronized with each cycle lasting about 15 minutes
(Kimmel et al., 1995). It is important to note that cells (blastomeres) that are
formed up to the 16 cell stage are incompletely separated from the yolk and are
observed to have non-yolky cytoplasm streaming to the animal pole (Kimmel
and Law, 1985a). In researching embryonic development it is possible to
inject large molecules such as mRNAs and morpholinos into the yolk and have
those molecules diffuse into the cells. At the end of the 16-cell stage, complete
divisions of the cells from the yolk begin to occur.
Blastula Phase (2 ¼ - 5 ¼ hours).
This phase begins with the eighth-cell cycle (128-cell stage) and lasts
until the 14th cell cycle (30% epiboly). Here, cells divide metasynchronously
up through cycle ten (512-cell stage), at which time the cycle lengthens and
zygotic transcription occurs, marking the beginning of the mid-blastula
transition (MBT) (Kane and Kimmel, 1993). Lengthening of cell cycle
interphases occurs independently, resulting in different cell cycle lengths and
asynchronous cell divisions.
The lengthening of interphases marks the initiation of cellular motility.
During the later stages of the blastula phase, cellular movements begin to
dictate embryo shape. Epiboly begins as cells in the blastoderm spread over
the yolk sac (Warga and Kimmel, 1990). This process of epiboly is akin to a
knit cap being pulled down over one’s head. The coverage of the yolk is
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described in a percentage, i.e., by 30% epiboly, 30% of the yolk area has been
covered with cells.
Gastrulation Phase (5 ¼ - 10 hours).
Gastrulation is defined by cellular involution and occurs at 50% epiboly
(Warga and Kimmel, 1990). Most cells at this stage are in their 15th cell cycle
and the maternal supplies of mRNA are nearly exhausted making zygotic
transcription necessary (Kane and Kimmel, 1993). Embryos that have been
injected early in development with the RNA polymerase blocker alpha
amanitin exhibit a block in morphogenesis by early epiboly (4.5 hours) but still
continue dividing until cell cycle 15 (8 hours) (Kane et al, 1996). At this point
the embryos eventually die. Formation of the primary germ layers and
embryonic axis occurs during the progression of epiboly due to the combined
morphogenetic cellular movements of involution and convergence extension
(Warga and Kimmel 1990). By the end of this phase, epiboly is complete, and
the basic body plan is laid down.
Segmentation Phase (10- 24 hours).
In this phase primary organogenesis and somite formation occur
(Kimmel et al., 1995). Many cells begin to differentiate and commit to cell
fates in the blood, pronephric and neural cell lineages. Cells that make up the
vasculature and primitive blood lineage, such as the erythrocytes, macrophages
and neutrophils, have formed and can be visualized by cell-type specific
markers via in situ hybridization. In the pronephros the pronephric ducts and
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podocytes have formed and in the nervous system the spinal neurons, mid and
hind brain boundaries, otic and optic structures are all visible with specific
markers. The embryo elongates and spontaneous body movements arise as the
nervous system matures.
Pharyngula Phase (24-48 hours).
The sixth and final phase of embryogenesis we will be concerned with
here is the pharyngula phase. While the majority of other tissues have formed,
the nervous system is still undergoing high levels of growth. Circulation
begins and the formation of the dorsal hollow nerve cord, notocord, and postanal-tail occur. During this phase, the differences between wild-type and ogre
mutant embryo development can be globally visualized.

Cell Cycle
The somatic cell cycle is divided into four phases: gap 1 (G1), synthesis
(S), mitosis (M), and gap 2 (G2). In G1, the cell normally is growing and
synthesizing proteins needed for the S phase. When sufficient levels of protein
are reached, the synthesis of DNA ensues marking the beginning of S phase.
During S phase, the genome is duplicated; and histone production typically
increases whereas RNA transcription and protein production tends to be low.
Genomic synthesis is complete as the cell cycle enters G2 during which protein
synthesis occurs until mitosis (review: Alberts et al., 2001).
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Mitosis divided into prophase (P), metaphase (M), anaphase (A), and
telophase (T) (Alberts et al., 2001). In prophase, the cells’ chromatin
condenses into chromosomes, the nuclear membrane breaks down, and the
spindle apparatus forms. Sister chromatids pair and microtubules from the
spindles at opposite poles within the cell connect to the kinetochores of the
sister chromatids. This results in the kinetochores of each sister chromatid
attaching to opposite poles of the spindle. The chromosomes are moved to the
center of the cell via the spindle microtubules. In metaphase, the sister
chromatids are properly aligned along the metaphase plate of the cell in
preparation for chromosomal segregation. In anaphase, the centromere
connection between the sister chomatids is lost and the chromatids are pulled
to the opposite poles. In telophase, the mitotic spindle disassembles, the
nuclear envelope reforms around the segregated chromosomes, and the
chromosomes decondense.
The remaining step of mitosis is the division of the cell into two
daughter cells by the process of cytokinesis (Alberts et al., 2001). This process
begins in anaphase and lasts through the completion of telophase. In anaphase
a cleavage furrow is formed by a contractile ring beneath the plasma membrane
is positioned in a plane midway between the spindle poles. The small GTPase
protein RhoA is activated at this position and in turn activates formins,
promoting the formation of actin filaments. RhoA also activates multiple
protein kinases resulting in the assembly of bipolar myosin II filaments and
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motor activity. It is this activity that contracts the contractile ring. Concurrent
with the ring contraction and the cleavage furrow ingression is the addition of
vesicle membranes adjacent to the contractile ring, accommodating the
increase in surface area required. The cleavage furrow is complete when the
plasma membrane is narrowed into a tether-like structure termed the midbody.
The midbody consists of the remaining central spindle complex of antiparallel
interpolar microtubules and a complex of associated proteins such as Racgap1
and Mitotic Kinesin-Like Protein 1 which participates in the final step of
cytokinesis known as the “abscission”. During abscission the microtubual
bundles disassemble on one side of the midbody bridge but remain intact at the
region they overlap in the midbody indicating the involvement of a severing
factor (review: Steigmann and Gerlich, 2009). Vesicles are trafficked to the
midbody by FIP3 (Simon et. al., 2008) with the membrane fission being
regulated by Endosomal Sorting Complex Required for Transport Complex
(ESCRT) (review: Steigmann and Gerlich, 2009). The three main models for
the final separation of the two daughter cells are mechanical rupture,
constriction of plasma membrane for fission, and the filling of the intercellular
channel by vesicles. In the mechanical force model cells are ripped apart by
traction forces and the membranes are repaired via cellular wound healing
mechanisms. In the constriction of the plasma-membrane-for-fission model,
the membrane continues to constrict as one side of the midbody bridge
disassembles, resulting in hemifusion and fission of the cellular membranes.
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The filling-of-intercellular-channel-by-vesicles model proposes that vesicles
accumulate around the severed bridge of the midbody and fuse the membranes
to complete the separation of the daughter cells (review: Steigmann and
Gerlich, 2009). Evidence for this model is the necessity of v- and t-SNAREs
(the membrane docking factors of endosomes and plasma membranes) for
abscission. Centriolin is recruited by the Mitotic Kinase-Like Protein 1 to the
midbody where it targets SNAREs and the Exocyst Complex (Gromley et al.,
2005).

ogre
The early arrest mutants ogre, zombie, and harpy were isolated from the
Tübingen screen (Kane et al., 1996). The Tübingen mutant screen was
designed to identify all of the genes that were necessary for early development.
In this endeavor, male zebrafish were mutagenized with N-ethyl N-nitrosourea
and out-crossed producing the G1 progeny which were randomly mated to each
other to make the G2 generation. From random matings of the G2 generation
the G3 embryos were screened for mutations (Haffter et al., 1996). A similar
mutagenesis screen with N-ethyl N-nitrosourea was performed at
Massachussetes General Hospital (MGH), however, no mutant similar to ogre
was discovered (Driever et al., 1996).
All of the early arrest mutants (ogre, zombie, speed bump and harpy)
arrest around cell cycle 15 (Kane et al., 1996). It is around cell cycle 15 that
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the maternally supplied mRNAs are depleted and when zygotic transcription
becomes necessary (Kane and Kimmel, 1993). At this point, if a cell in a
mutant animal has not undergone its final division, cell cycle arrest occurs and
the cell can no longer divide. In zombie, cells that arrest in the cell cycle can
not complete differentiation and arrest in mitosis. In harpy and ogre mutants
these cells can still differentiate despite their enlarged size and inability to
divide.
In the case of ogre mutants, the block in the cell cycle appears to occur
at the final stage of mitosis during the abscission step in cytokinesis. Time
lapse photography conducted by Kane in 1996 (unpublished) showed that
dividing cells in ogre mutants formed the typical ingressed cleavage furrows
observed during cytokinesis, but remained connected to each other through a
thin cytoplasmic midbody. These connected cells moved apart from one
another, but eventually fused back together as the cleavage furrow regressed
resulting in one large cell with more than one nucleus. As embryogenesis
progresses this phenotype subtly changes so that rather than a midbody
forming within the cells, incomplete furrow ingression is followed by
subsequent furrow regression (Fig. 1). Regardless, this abnormal cytokinesis
still results in large multinucleated cells.
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Figure 1. Cytokinesis failure in ogre mutants. In the early ogre mutant embryo (1)
cleavage furrow ingression occurs and the cells begin to move apart but later will fuse
back together as the furrow regresses (2, 4). Later on less furrow ingression is seen
before furrow regression and cell fusion occurs.

Racgap1
Racgap1 was initially identified in mutant screens in Drosophila and
Caenorhabditis elegans. In many of these mutants, larger than normal cell size and
multinucleated cells were observed. In humans MgcRacGap is the homologue of
Racgap1 (Touré et al., 1997). It was identified through yeast-2-hybrid screens by
Touré et al. in 1997 looking for partners of Rac GTPase. The MgcRacGap protein is
variably expressed in different tissues, with the highest expression found in male
germ cells and tumor cells. Transient expression of mutant MgcRacGap in 293T cells
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resulted in multinucleated cells (Hirose et al., 2001). In Drosophila the Racgap1
homologue mutant, tumbleweed (tum), was discovered in 1999 during a genetic
screen to identify genes involved in dendritic morphogenesis (Gao et al., 1999). The
tum mutants had fewer cells that were larger in size than cells in wild-type embryos
and their neurons exhibited excessive dendritic branching as well as axonal
misrouting and outgrowth defects (Goldstein et. al., 2005). RNA interference studies
of Racgap1 in Drosophila S2 cells resulted in multinucleated cells (Somma et al.
2002). In C. elegans, the Racgap1 homologue mutant cyk-4 was discovered in 1999
during a screen for maternal effect lethal mutations on chromosome III (Gönzy et al.,
1999). Cells in cyk-4 mutants exhibit furrow regression following initiation of the
cleavage furrow similar to what is observed during cytokinesis in older zebrafish ogre
mutants.
Racgap1 is a GTP-ase activation protein (GAP) protein that interacts directly
with RhoA and has been shown to be necessary for the abscission step in cytokinesis
(Minoshima et al., 2003; Simon et al., 2008). Abscission is the final step in
cytokinesis in which the membranes of the daughter cells are separated. Mutations in
Drosophila and C. elegans, Racgap1 homologs tumbleweed and cyk-4 cause cells to
not properly divide resulting in larger cells with multiple nuclei (Gao et al.1999,
Glotzer et al 2000). This is exactly the phenotype of ogre mutants.
At the molecular level Racgap1 consists of four functional domains (Fig. 2 A).
The first protein domain is a coiled-coil domain. The coiled-coil domain results in
the formation of two alpha helixes and functions in many protein-protein binding
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interactions especially with other proteins containing coiled-coil domains. The
second domain is the low complexity domain. The third domain is the Dag-PE
binding domain. The Dag-PE binding region of the protein has been shown to bind to
RasGTP, phorbol esters and diacylglycerol. The fourth domain is RhoGAP. This
domain plays a major role in cytokinesis where it inactivates the small G-protein
RhoA.
During anaphase Racgap1 is recruited to the midzone where through its
coiled-coil domain, it binds to the coiled-coil domain of MKLP1 (Mitotic KinesinLike Protein 1) forming the centralspindlin complex (Jantsch-Plunger et al., 2000).
MKLP1 subsequently binds to the anti-parallel microtubules and stabilizes the
spindles forming in the midzone (Nislow et al., 1992; Raich et al., 1998). The
protein, anillin, is recruited to the midzone and binds to the Dag-PE domain of
Racgap1 (Gregory et al., 2007). Anillin then recruits septins and interacts with actin
and myosin II to localize the actomyosin contractile ring to the midzone (Gregory et
al., 2007).
Racgap1 also binds ECT2, a GEF protein that is recruited to the midbody
during anaphase and telophase (Simon et al., 2008) (Figure 2 B). ECT2 activates the
small G-protein RhoA by stimulating the RhoA’s bound GDP (Tatsumoto et al.,
1999). This results in GTP binding to and activation of RhoA. Once RhoA is
activated, the contractile ring contracts and cleavage furrow ingression occurs (Kishi
et al., 1992; Jantsch-Plunger et al., 2000). In late telophase, ECT2 is recruited back to
the newly forming nuclei leaving Racgap1 at the midbody (Chalamalasetty et al.,
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2006). The furrow ingression stops at the midbody as Racgap1 binds to and
inactivates RhoA (Minoshima et al., 2003). RhoA dissociates from the cleavage
furrow leaving Racgap1 free to interact with FIP3 (of which FIP3 is complexed with
Rab11-,Eferin, arfophillin) (Simon et al., 2008). FIP3 interacts with Racgap1 and the
Exocyst Complex which targets and tethers vesicles to the furrow to complete the
final step in cytokinesis, the abscission step (Simon et al., 2008).
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Figure 2. Racgap1 functional domains and its role in cytokinesis. A) Illustrated of
Racgap1 domains and their binding partners involved in cytokinesis. B) The two
phases of cytokinesis: furrow ingression, and abscission. B.1) Racgap1 (maroon)
and MKLP1 (purple) form the centralspindlin complex and bind the RhoA GEF
ECT2 protein (yellow). ECT2 activates RhoA causing furrow ingression to occur.
B.2) ECT2 is recruited to the forming nuclei and leaves the centralspindlin complex.
Racgap1 inactivates RhoA stopping the furrow ingression and binds to FIP3. The
binding of FIP3 results in the vesicle delivery and abscission (Simon et al, 2008).
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Cell Fate and Cell Divisions
Cell fate divisions in the developing embryo occur either symmetrically
or asymmetrically. Symmetric fate divisions result in two cells that have
similar fates. Asymmetric fate divisions on the other hand, produce two cells
with different fates. Asymmetry can be derived either from the micro
environment, the segregation of intrinsic molecules during cell cleavage, or a
combination of the two. For many tissues the environment provides
asymmetric cues that result in different cell fates. In environmental
asymmetry, the direction of cell division results in two cells being exposed to
different environmental cues, thus causing each to acquire a different fate from
each other (Horvitz and Herskowitz, 1992). However, some tissues utilize the
asymmetric division of intrinsic molecules to determine different cell fates. In
the invertebrate Drosophila, neural differentiation of a neuroblast stem cell into
a ganglion mother cell (GMC) is a result of the asymmetric segregation of the
intrinsic protein Numb (Knoblish et al., 1995; Rhyu et al., 1994). A second
asymmetric division of the GMC partitions the Numb transcription factor into
only one of these progeny, creating two different neural fates (Rao 2001). In
some lineages this unequal distribution of Numb inhibits Notch signaling,
causing one daughter cell to differentiate as a neuron, whereas often the other
daughter cell initiates apoptosis (Lundell et al., 2003; Karcavich, 2005; Kumar
et al., 2009; Orgogozo et al., 2002). While less is known about asymmetric
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cell division in vertebrates, there is some evidence that in the developing
mouse brain, defined neural progenitors also asymmetrically segregate Numb
(Shen et al., 2002) and have repeated patterns of asymmetric divisions that
include cell death (Shen et al., 2006). This indicates that some of the same
mechanisms of asymmetric cell division are likely conserved.
Other tissues that may utilize the asymmetric segregation of intrinsic molecules
include the skin. In the developing mouse, basal stem cells are polarized to
divide asymmetrically resulting in two different daughter cells (Lechler T and
Fuchs, 2005). When asymmetric cell divisions (oriented cell divisions) are
blocked, Notch activity is not segregated properly, thus stratification and
differentiation of the skin does not occur (Williams et al., 2011). The kidneys
have also been shown to require oriented cell divisions for proper tissue
formation (Williams et al., 2011; Simons et al., 2009; Fischer et al., 2006).
When oriented cell division fails, defects in tubulogenesis and podocyte
structure occur. If proper cell division is necessary for neural, epithelial and
kidney development, what will be their fates in the ogre mutant when a cell
cannot divide?

Summary
In this thesis, using a variety of methods, I more carefully characterize
the cellular and morphological defects of the ogre mutant embryo. In addition,
I demonstrate via linkage analysis, DNA sequencing and in situ hybridization

16
experiments that the zebrafish mutant ogre is the result of a mutation in the
zebrafish homolog of Racgap1.
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CHAPTER II
CHARACTERIZATION OF THE OGRE MUTANT
PHENOTYPE
Background
Morphological and Cellular Phenotype of ogre Mutants
In the initial study of ogre mutants, it was found that multinucleated cells
appeared after cell cycle 15, approximately at the gastrulation stage of developing
embryos (Kane et al., 1996). It was not clear, however, when the ogre mutants
cellular phenotype first appeared nor how the number of multinucleated cells
increased over the course of development. In addition, there had been no detailed
morphological characterization of the ogre mutant. In this section of my thesis I will
characterize the ogre mutant in greater detail. First I focus on the general loss of
optical transparency and the onset of cell death in the ogre mutant. Next I show what
consequence this has for morphogenesis, in particular on the development of the
central nervous system and pronephros. Finally I determine when cells become
multinucleate in the ogre mutant, and how this cellular phenotype progresses over
time.
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Results
Characterization of the Morphological ogre Mutant Phenotype
In the following experiments I used embryos derived from breeding pairs of
zebrafish heterozygous for ogre. Animals with the ogre mutant phenotype are
homozygous recessive for the lethal allele and therefore these crosses resulted in
approximately one quarter of the embryos with the ogre mutant phenotype; the
remainder of embryos had the wild-type phenotype. Wild type and ogre mutant
embryos were collected and staged at the blastula stage so that all of the embryos
would be isochronic; thereafter they were stored at either 25˚C or 30˚C until the
appropriate stage.

Loss of Optical Transparency
To gain more detailed understanding of the ogre mutant phenotype, I
determined when it first appears and how it develops at the gross morphological level.
Wild-type and ogre mutant sibling embryos are morphologically
indistinguishable at the 4-somitess stage of development except perhaps for a slightly
shorter body axis. However, by the 6-somites stage, approximately an hour later,
ogre mutant embryos show a noticeable loss of optical transparency in the head and
central nervous system (Fig. 3). In addition, the optic placode is reduced in size and
the body axis is shorter than that of wild-type. These phenotypes also occur in the
cell cycle mutant harpy (Riley et al., 2010), likely because mutant embryos already
possess fewer cells than wild-type embryos even as they try to undergo global
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patterning. One and a half hours further into development, at the 9-somites stage,
ogre mutant embryos lack nearly all optical transparency in the head and central
nervous system resulting in significant reductions of identifiable head structures.
Moreover, the body axis is markedly shorter. By 24 hours, the head in ogre mutant
embryos is completely black and devoid of any discernible head structures. Now, the
loss of transparency is also evident in the spinal cord. The somites in ogre mutants
appear more blocky in shape instead of the normal ‘boomerang’ appearance as in
wild-type, and the tail appears shortened. While wild-type embryos spontaneously
wiggle, mutant embryos are mostly motionless, however, in the few that do exhibit
movement the number, range of motion and fluidity is significantly lower than that in
the wild-type.
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Figure 3. Characterization of the ogre mutant phenotype. All embryos are left side
views, with anterior to the left. A, D) 4-somites stage wild-type and ogre mutant
sibling. Embryos are indistinguishable from one another except that ogre mutant has
a slightly greater distance between the head and tail (red line) (D). B, E) At the 6somites stage wild-type and ogre mutant sibling. ogre mutants are now discernible by
an increasing loss of optical transparency in the brain and spinal cord, smaller eye
primordium and the greater distance between the head and tail. C, F) The 9-somites
stage wild-type and ogre mutant sibling. Mutant embryos show increased loss of
optical transparency in both the brain and spinal cord. The eye is no longer visible,
the head is more reduced and the distance between the head and tail has again
increased.
Global Pattern of Cell Death
The most prominent feature of the ogre mutant phenotype is the loss of optical
transparency in the head and trunk. One explanation for the loss of optical
transparency is that cells are dying. In the rat Citron Kinase mutant, neural progenitor
cells in specific areas of the brain fail to complete cytokinesis and subsequently die
(Mitchell et al., 2001; Sarkisian et al., 2001). A similar situation could be occurring
in ogre mutants. The most common ways cells die is by apoptosis or by necrosis,
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both of which are well characterized. Necrosis is considered a passive form of cell
death often caused by external factors such as toxins or trauma that damage the cell
and lead to its demise (review in Alberts et al., 2001; Miyake and Yamasaki, 2012).
Whereas in apoptosis the cell undergoes an active form of cell death carried out by
intrinsic programs within the cell whose purpose is to dispose of superfluous or
abnormal cells in a non-inflammatory manner (review in Alberts et al., 2001; MuñozPinedo, 2012; Schultz and Harrington2003). During this process the cell shrinks,
condenses its nuclear envelope and fragments its DNA. The cell then breaks apart
into apoptotic bodies that are quickly phagocytosed. It is this type of cell death that
occurs in the Citron Kinase mutant (Mitchell et al., 2001).
To determine if the loss of optical transparency in ogre mutants was due to
cell death, I employed an assay commonly used to look for dying cells in live
embryos. Acridine orange (AO) is a cell permeable vital dye that binds to nucleic
acid and fluoresces in the green wave length when bound to DNA. In dying cells the
signal is more intense however, this is probably due to the condensation of DNA
within those cells. It has been reported to label apoptotic cells in Drosophila (Abams
et al., 1993) and has been used to visualize cells potentially dying by apoptosis in
zebrafish (Furutani et al., 1996). Nevertheless, it is not only specific to apoptotic cells
as necrotic cells can also be stained.
A more specific assay commonly used to visualize apoptotic cells is TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end labeling). TUNEL detects the
fragmentation of the DNA occurring during the last stage of apoptosis (Gavrieli et al.,
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1992). However, because TUNEL is an expensive technique, we chose to employ the
AO assay for our ogre mutant analysis.
One of the caveats to using AO is that it can induce cell death if the
concentration is too high. Therefore I first compared AO staining in my wild-type
embryos to the experimental results of Cole et al. (2001), who utilized TUNEL
staining to identify the normal pattern of apoptotic cells throughout embryogenesis in
the zebrafish (Cole et al., 2001). After adjusting the AO concentration to a level that
did not induce cell death, but was concentrated enough to stain the naturally dying
cells within the embryo, I obtained results similar to the TUNEL study (data not
shown).
Next I characterized the timing and pattern of cell death in ogre mutants. AO
staining of ogre mutant embryos revealed a detectable phenotype that coincided with
areas that later lost their optical transparency (Fig. 4). At the 4-somite stage, there
were high levels of AO stained cells in the brain region of ogre mutant embryos and
by the 6-somites stage, high amounts of AO stained cells were now also visible
within the spinal cord. By the 20-somites stage, high AO staining was widespread
throughout much of the central nervous system and along the ventro-posterior aspect
of the tail. What little tissue that remained in the ogre mutants head also appeared
AO positive. In comparison, levels of AO staining in wild-type embryos remained
low throughout development consistent with the observations of Cole et al. (2001).
In summary, my results indicate that loss of optical transparency in the ogre mutant is
likely due to elevated levels of cell death. Furthermore, most of the cell death occurs
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in the nervous system where proper cell division is critical for survival (Mitchell et
al., 2001; Sarkisian et al., 2001; Ackman et al., 2007). While not definitive, my AO
staining strongly suggests that these mutant cells are dying by apoptosis and not
necrosis. Further studies done with anti-activated caspase 9 staining of ogre mutants
(a key protease activated in the apoptotic cascade) revealed similar staining patterns
in ogre mutants (Dr. Rachel M. Warga, unpublished).

Figure 4. ogre mutants show increased amounts of cell death. All embryos are
stained with acridine orange and present as left side views, with anterior to the left.
A, D) 4-somites wild-type and mutant sibling. By 4-somite stage ogre mutants have
intense acridine orange staining in the head along with some staining in the trunk. B,
E) 6-somite wild-type and ogre mutant sibling. Cell death in ogre mutants has
spread throughout the brain and trunk. C, F) By 20-somites wild-type embryos are
observed to have cell death in the brain and along the spine. In ogre mutants (F) what
little structure remains in the brain is stained. Intense staining in the tail region where
erythrocyte proliferation occurs is also observed.
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Analysis of Normal Tissue Development by Gene Expression
Mechanisims of cell proliferation and fate determination vary among different
tissue and cell types. Tissues such as the blood and central nervous system undergo
many rounds of stem cell divisions, producing many cells that commit to different
cell fates within their tissues (Kimmel and Warga, 1986, Kimmel et al., 1994; blood:
Warga et al., 2009). Other tissues such as the notochord and hatching gland stop
dividing much earlier around cell cycle 14 and 15, and commit to single fates
(Kimmel et al., 1994; Kimmel and Warga, 1996).
To look at tissue morphogenesis in the ogre mutant, I performed whole mount
in situ hybridizations expressing a variety of markers to look at general
morphogenesis of the nervous tissue at 24-26 hours of development. At this time, the
zebrafish has a well-developed nervous system with characterized regions that
include the forebrain, midbrain, hindbrain and spinal cord, as well as a number of
placodally-derived structures such as the olfactory, optic and otic vesicles (Kimmel et
al., 1995). In addition, there are many identifiable cell types. Despite the lack of cell
division following gastrulation, many, but not all of these structures and cell types
formed in ogre mutant embryos albeit with fewer cells that were much bigger in size
compared to wildtype (Fig. 5). In the head, distal-less 3 (dlx3) is expressed in both
the otic vesicles and olfactory placode (Cohen et al., 1989; Akimenko et al., 1994).
While the otic vesicle was absent in ogre mutant embryos, the olfactory placode did
form (Fig. 5 A). In the head, islet1 is expressed in the epiphysis and cranial motor
neurons, while in the trunk it is expressed in dorsal sensory neurons and spinal motor
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neurons (Korzh et al., 1993; Inoue et al., 1994). The ogre mutants lack cranial and
spinal motor neurons; however, they form dorsal sensory cells as well as the
epiphysis (Fig. 5 B). This discrepancy in motor neurons may be due to their later
time of birth, which occurs during segmentation (Myers, 1985). The dorsal sensory
neurons, however have among the earliest neural birth at about 9 hours of
development, about cycle 15 (Mendelson, 1986). Finally expression of alpha
collagen 2 (col2a) in the hypochord and floor plate (Yan et al., 1995) revealed that
these structures formed, but the floor plate is discontinuous in ogre mutants (fig 5 C).
In summary, despite the cytokinesis defects, overt patterning of the nervous system
appears somewhat normal in ogre mutants.

26

Figure 5. Overt morphogenesis of the nervous system appears somewhat normal in
the ogre mutant. All embryos are presented as left side views, with anterior to the
left. A, B) Expression of dlx3 at 24 hours, wild-type and mutant sibling. Note the
presence of the olfactory placode and branchial arches in the mutant. C, D) islet1
expression at 25 hours in wild-type and ogre mutant sibling. The pancreas, epiphysis
and dorsal sensory neurons, and cranial motor neurons are all present in ogre mutant.
E, F) col2a expression in wild-type and ogre mutant sibling at 25 hours. Note the
presence of the notochord and floor plate in the mutant. Figure abbreviations for otic
vesicle (ov), branchial arches (ba) olfactory placode (op), cranial motor neurons
(cmn), dorsal sensory neurons (dsn), spinal motor neurons (smn), pancreas (p),
epiphysis (e), notochord (nc), and floor plate (fp).
To examine in more detail areas of the nervous system, where cell types were
missing in the ogre mutant, we looked at more specific markers of the brain and
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spinal cord (Fig. 6). The zebrafish hindbrain is composed of seven segments known
as rhombomeres. The gene Krox20 is expressed in two of these rhombomeres, three
and five (Thisse et al., 2001). Initially, the expression of krox20 was similar in both
mutant and wild-type, but by 24 hours it was reduced to only one unidentifiable
rhombomere in the mutant (Fig. 6 B, D). pax2a expression occurs in the hindbrain,
midbrain, otic placode, pancreas, pronephros, intermotor neurons, eye, and optic
stock (Krauss et al., 1991). In ogre mutants dorsal structures such as the midbrain,
hindbrain, otic placode, optic stock, and eye are all missing (Fig. 6 F). tal1 is
expressed in ventral brain and spinal interneurons as well as in the ventral midbrain
(tegmentum) and blood (Liao et al., 1998). Like the cranial and spinal motor neurons
above (visualized with islet1) there were no cranial or spinal interneurons and few
tegmental neurons in the ogre mutants (Fig. 6 H). dlC is expressed in a number of
structures including the dorsal midbrain (tectum) and the optic retina (Haddon et al.,
1998). In ogre mutant embryos, both tectum and neural retinal cells were missing
(Fig. 6 J). We can conclude that, up to this point with respect to the cytokinesis
defects of ogre mutants, the cells that take on early fates in the nervous system are
somewhat normal whereas the later aspects of the developing nervous system are
more affected.
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Figure 6. Missing neural structures in ogre mutants. A-B, E-F) Dorsal view with
anterior toward the left. C-D, G-J) Embryos present as left side views, with anterior
to the left. A-D) krox20 expression in wild-type and mutant sibling. A-B)
Expression at 10-somites stage (10S) in the mutant (B) appears wild-type. C-D) Note
the loss of a rhombomere in ogre mutants. E-F) pax2a expression at 26 hours of
development. Complete loss of ventral structures in ogre mutants. G-H) tal1
expression in 26 hour wild-type and mutant sibling. Note the loss of interneurons in
ogre mutants. I-J) Expression of dlC at 25 hours. ogre mutants lacks tectum and
retina staining. Figure abbreviation for rhombomere 3 (r3), rhombomere 5 (r5),
midbrain (mb), hindbrain (hb), otic vesicle (ov), interneurons (in), retina (rt), and
tectum (t).
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As I demonstrated above, not all neurons are missing in the ogre mutant.
Neurons in the Drosophila Racgap1 homolog mutant, tumbleweed, exhibit excessive
dendritic branching and have axon guidance defects (Gao et al., 1999). Thus, I
investigated whether similar defects occurred in ogre mutants. Acetylated tubulin
staining of neurons revealed that the dendrites of characterized neurons such as the
trigeminal neurons exhibited atypical and excessive branching across the yolk cell.
Likewise axons of identified primary motor neurons in the trunk lacked their normal
patterns of innervation (Fig. 7). Thus, consistent with the tumbleweed mutant
phenotype in Drosophila, ogre mutant neurons show equivalent defects.

Figure 7. Excessive neuronal branching in ogre mutants. A-F) Acetylated tubulin
staining of neurons at 24 hours. A, B) Wildtype and mutant siblings under low
magnification. C-F) High magnification views of wildtype and the mutant sibling.
C, E) Dorsal views with heads to the left. D, F) Wildtype and ogre mutant sibling
views of the presumptive dorsal sensory neurons. B, E, F) The mutant shows axonal
branching disorganization of the axons.
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While I show there are severe patterning defects in the nervous system of ogre
mutants by 24 hours, the krox20 staining indicated that earlier development was
perhaps somewhat normal. Therefore I looked at the time course of deltaA
expression in the mutant to determine if such was the case. delta A (dla) is one of the
principle ligands in the Notch signaling pathway essential in regulating neural fate. It
is transiently expressed in cells that have committed to a neural fate, but have not
completely differentiated (Chitnis et al., 1995; Cornell and Eisen, 2000). Analysis of
dla expression revealed normal expression in ogre mutant embryos up to the 10somites stage. However, as development proceded, the number of dla-positive cells
in the mutant decreased until there were only a handful of cells by 26 hours. This was
in marked contrast to wildtype where the number of dla-positive cells increased
exponentially (Fig 8 A-H). Using BrdU to visualize cells that were still dividing, and
thus synthesizing DNA, I asked if these dla-positive cells in the ogre mutant were
cells that had escaped the cell cycle before the ogre mutant cytokinesis defect
occurred. The majority of these dla-positive cells possessed two or four labeled
nuclei (inset Fig. 8 H) indicating that these differentiating cells were not dividing.
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Figure 8. The numbers of neural progenitors and stem cells decline over time in ogre
mutants. All embryos present as left side views, with anterior to the left. A-H)
Expression of delta A (dla) in the neural progenitors at: the 13-somite stage (A, B),
the 16-somite stage (C, D), the 20-somite stage (E, F), and at 26 hours (G, H). Note
the increasing loss of neural progenitors in ogre mutants. Inset in H shows a single
dla-positive cell labeled with BrdU that has two nuclei (indicated with arrows). I-J)
Expression of notch1b in 26 hour wild-type and mutant siblings. Note the greatly
reduced levels of notch1b in ogre mutant.
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Notch1b, a Notch receptor in the Notch signaling pathway, is expressed in the
precursor population to dla, in the undifferentiated dividing neural stem cells
(Bierkamp and Campos-Ortega, 1993). Expression of notch1b revealed a similar
death of neural progenitor cells in the ogre mutants at 25 hours (Fig. 8 I, J). Thus, it
seems that once neural cells have to choose between proliferating or differentiating,
being multinucleate may result in cell death, an idea I tested below looking at blood
cell populations.
Like neural cells, blood undergoes many rounds of stem cell divisions. In the
zebrafish, there are four types of blood cells by 48 hours of development. These
include macrophages, which derive from a lineage that produces only one cell type
and divides infrequently, as well as erythrocytes, neutrophils and platelets, which
derive together from a common lineage that undergoes frequent rounds of cell
division (Warga et al., 2009). Using the macrophage marker lcp1 (Herbonel et al.,
1999), the erythrocyte marker hbbe2 (Brownlie et al., 1998) and the neutrophil
marker mpx (Lieschke 2001; Bennett et al., 2001) I determined that ogre mutants had
all three types of cells (Fig. 9). Next, I asked how these two different blood lineages
differed in ogre mutant embryos. Counting the number of macrophages, erythrocytes
and neutrophils at three different developmental stages revealed that, with the
exception of erythrocytes, the number of cells within each blood cell type remained
nearly constant from first appearance until our last observations at 33 hours (Fig. 10).
Erythrocytes, on the other hand, dropped in number between 18 and 26 hours.
However, similar counts were obtained for erythrocytes at 26 and 33 hours. This
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could be explained by erythrocytes being the putative dividing stem cells (Warga et
al., 2009), and that death occurs between 18 and 26 hours in the ogre mutant because
of the cytokinesis defect. As I show later, racgap1 mRNA is normally expressed in
presumptive erythrocytes at 26 hours. Thus, as in the nervous tissue, improper cell
division likely causes death in cell populations that have asymmetric cell divisions
(erythrocytes).
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Figure 9. ogre mutants form most blood types. Expression of various blood markers
at 25 hours of development. All embryos are left side views, with anterior oriented to
the left. A-B) Expression of hbbe2 in erythrocyte cells in wild-type and ogre mutant
siblings at 25 hours. C-D) Expression of lcp1 in macrophage cells in wild-type and
ogre mutant siblings at 25 hours. E-F) Expression of mpx in neutrophil cells in wildtype and ogre mutant siblings at 25 hours. All the various cell types are present, but
are fewer in number and greater in size in ogre mutants.
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Figure 10. Erythrocytes are reduced in number in the ogre mutants. For each cell
type a total of 5 animals were counted at each stage. For erythrocytes (hbbe2-positive
cells) cell numbers in wildtype increased between the three stages. In ogre mutants
the number of erythrocytes instead falls between 18 and 26 hours, before stabalizing
at 26 hour numbers. Macrophage (lcp1) and neutrophil (mpx) numbers remain
constant.

The last tissue I examined is the kidney as there is some evidence that there is
asymmetric cell polarization within the proliferating cells of the tubules and
podocytes (Simons et al., 2009; Fischer et al., 2006). The embryonic kidney of
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zebrafish consists of two paired pronephric nephrons that have a segmented
organization similar to that of their mammalian counterparts (reviews: Wingert et al.,
2008; Drummond I, 2003). Expression of ndrg1a, which labels the whole pronephros
at 26 hours (Puijic et al., 2006), revealed that the most anterior segment consisting of
the podocytes appeared to be missing in ogre mutant embryos (Fig. 11 A, B). This
was confirmed using expression of wt1, which specifically labels the podocytes (Fig.
11 D, E) (Drummond et al., 1998). To determine if loss of wt1 expression was unique
to ogre mutants and not a general feature of having fewer cells in the embryo, I
looked at another cell cycle mutant. harpy is a mutation in the early mitotic inhibitor
1 gene, whose product negatively regulates cell cycle progression from metaphase to
anaphase. As a result cells in the harpy mutant arrest before dividing (Kane et al.,
1996; Zhang et al., 2006; Riley et al., 2010). The block in the cell cycle appears to
occur at about the same time as ogre mutant, cycle 15, but cells in harpy mutants
rarely die (Riley et al., 2010). ndrg1a expression revealed that podocytes form in
harpy mutants (Fig. 11 C). Although very preliminary, my data suggest that the
podocyte lineage is more sensitive to improper cytokinesis, possibly due to its
requirement for planar divisions.
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Figure 11. ogre mutants lack the podocyte segments in the pronephros. All embryos
present as left side views, with dorsal views, head to left. A-C) ndgr1a expression in
wildtype (A), ogre mutant sibling (B) and harpy mutant (C) at 26 hours. ndgr1a
labels the entire pronephros. B) The mutant ogre lacks anterior segments. D, E)
wt1a expression in wild-type and ogre mutant sibling at 26 hours. wt1a labels the
podocytes specifically. Note the absence of podocytes in ogre mutants.
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Characterization of the ogre Mutant at the Cellular Level
Thus far I have concentrated on gross morphological features of the ogre
mutant. To gain insight at the cellular level and access when cells became
multinucleate and how this phenotype progressed, I stained embryos at more
developmental stages beginning at 70% epiboly, with DAPI, a fluorescent DNA
marker (Kapuściński and Szer, 1978). At first I tried staining whole embryos, but it
was difficult to resolve the cell boundaries or the multiple cell layers within the
embryo (Fig. 12). To eliminate this problem I dissociated whole embryos into
individual cells, as described in Riley et al. (2010). Briefly, embryos were digested
with collagenase, and the nuclei of individual cells stained with DAPI before
examination at high magnification on a hemocytometer. Using this method, I
calculated the relative ratios of cells in the embryo having one, two, or four nuclei at
specific embryonic stages for wild-type and ogre mutant individuals (Fig. 13). The
stages I concentrated on were 70% epiboly, tailbud, 4-somites stage, 10-somites stage
and the 20-somites stage.

Figure 12. DAPI stained whole ogre mutant embryo at 20-somites stage. An ogre
mutant embryo stained with DAPI and squashed between cover slips. Due to
multiple layers of cells in the embryo, individual cells cannot be scored for their
nuclear content.
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C
Figure 13. DAPI stained dissociated cells. A-B) Representative 100x magnification
views of individual wild-type and ogre mutant embryos after treating with
collagenase and staining with DAPI, and visualized on a hemocytometer with UV
lighting. C) Representative high magnification views (200x). Examples of the
different multinucleated states visualized after collagenase dissociation and DAPI
staining.

At 70% epiboly, cells of the embryo are approximately at cycle 15, when most
maternal mRNA stores have been exhausted (Kane and Kimmel, 1993). The cell
cycle at this point is relatively short and, as a result, a large portion of cells are in late
anaphase and telophase and therefore have double nuclei. Indeed I observed roughly
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ten percent of cells with double nuclei. At this stage, I could not distinguish the
mutant embryos from the wild-type embryos morphologically; however at the cellular
level there appeared to be a weak ogre mutant phenotype (Fig. 14 A). Since the ogre
mutation is recessive, simple Mendelian genetics predicts that 25% of the embryos
would be homozygous for the ogre mutation. Indeed I one quarter of the individuals
(n=4/16), appeared to have slightly higher percentages of double nuclei cells
compared to the rest of the embryos (compare Embryos 1-4 to Embryos 5-16).
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Figure 14. Characterization of the ogre mutant multinucleate phenotype. A-E) The
multinucleate state for the individual embryos from a single cross (clutch). Each
embryo is indicated by a vertical bar that shows the percent of population that were
mononucleate, binucleate or quadnucleate. C-E) 4-somites (4S), 10-somites (10S),
and 20-somites (20S) staged embryos showing the progression of the ogre mutant and
wild-type cellular phenotypes. A) At 70% epiboly, a possible subtle ogre mutant
phenotype may be observed in the slightly higher binucleated percentages in embryos
1-4. B) Embryos at tailbud show a definite ogre mutants multinucleated cellular
phenotype as indicated by the increased percentages of binucleate and quadnucleated
cells. C) At 4-somites the mononucleated cells represent less than 60% of the total
cells in the ogre mutant embryos (embryos 1-6) . D) At the 10-somites stage
approximately 10% of the cells in ogre mutants are quadnucleated. E) By the 20somites stage less than 50% are mononucleate with 30% of the cells in ogre mutants
being quadnucleated.
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Two hours later, at the tailbud stage, still before I can morphologically
distinguish ogre mutants, there was a clear cellular phenotype in one quarter of the
individuals (n=4/16) (Fig. 14 B). In this stage cells appear containing quad-nuclei,
and in such embryos there was a corresponding decrease of cells containing a single
nucleus. By comparison, the rest of the embryos had a low percentage of
multinucleated cells (~3%) similar to the majority of embryos at 70% epiboly. By the
4-somites stage, the differences were even more obvious between presumptive mutant
and wild-type embryos as one quarter of the individuals (n=7/20) generally had more
cells with two and four nuclei than they had cells with a single nucleus (Fig. 14 C).
As in the previous stages, the remainder of embryos had few multinucleated cells.
Furthermore, the percentage of multinucleated cells actually decreased as a whole in
the presumptive wildtype, in keeping with the cell cycle lengthening and there being
fewer cells in telophase. Notably, the percentage of multinucleated cells in wild-type
embryos decreases as development progresses. No wildtype embryos contained cells
that had four nuclei.
Following the 4-somites stage, the number of multinucleated cells in ogre
mutants remained relatively constant, and strikingly different from wildtype, both at
the 10-somites (Fig. 14 D) and 20-somites stage (Fig. 14 E).
Figure 2.11 shows only the embryos from a single clutch. However, except
for 70% epiboly, I looked at a number of different clutches for each of the various
stages. To determine how uniform the ogre mutant cellular phenotype was, I
compared the numbers from different clutches (Fig. 15 A-D). The relative distribution
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of nucleated states (mono, bi, and quad) for each stage is not highly variable within
the mutant category and in no way resembles the distribution within the wild-type
category (here I show only the average from one representative clutch). Comparing
the combined data for each stage (Fig. 15 E) reveals that between the 4-somites and
10-somites stages, the proportion of cell that have multiple nuclei decreases in ogre
mutants. This temporary decrease in highly nucleated cells coincides with our
previous observation that large numbers of cells begin to die in ogre mutants at
around the 6-somites stage (Fig. 4). Hence the reduction in higher multinucleated
states is most probably the result of cell death. At these stages I could now
distinguish mutants based on their morphological appearance before the collagenase
treatment, suggest that my assumptions at previous stages are likely correct: that as
early as 70% epiboly the mutant phenotype is present, and certainly by tailbud stage,
cells in ogre mutants begin failing to complete cytokinesis.
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Figure 15. The ogre mutant cellular phenotype is highly consistent. Shown are the
averages for each clutch at a single stage so as to compare clutch to clutch variations.
Only slight differences between ogre mutant clutches are observed. Due to the highly
consistent numbers in wildtype, individuals from several clutches were grouped, and
the averages from these groups were used. A) Clutches were very similar at the
tailbud stage. B) At the 4-somites stage (4S) the proportion between the nucleated
states were fairly consistent with some variability of the mononucleate and binuceate
proportions. C) At the 10-somites stage (10S) the proportions between the different
nucleation states are very consistent. D) At 20-somites (20S) we see very consistent
proportions between the different clutches. E) All of the clutches within each stage
were averaged together. Note the shift of multinucleated proportions between the 4somites and 10-somites stage. This correlates to the cell death pattern we see in the
ogre mutants.
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Summary
In this section I characterized the ogre mutant phenotype in greater detail. My
acridine orange staining revealed that higher levels of cell death occurred in ogre
mutants and that this occurrence preceded the morphological phenotype by two hours.
My more in depth analysis of the morphological phenotype revealed that loss of
optical transparency was due to cell death, and that this was first visible by 6-somites.
Through my in situ hybridizations it was revealed that although most tissues formed,
in some tissues, such as the neural, kidney and erythrocyte tissues, losses of cells and
tissue formation occurred. I also characterized the cellular phenotype in detail
showing that the multinucleated cellular phenotype of ogre mutants first appears
around 70% epiboly and that only in ogre mutants did these numbers increase as
development progressed. In the next two sections I will show that the cause for this
phenotype lies in a null mutation of the Racgap1 gene.
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CHAPTER III
GENETIC MAPPING OF THE OGRE LOCUS TO RACGAP1
Background
The Zebrafish Genome
The zebrafish genome is estimated to be approximately 2 GB (Hubdard et al.
2009). In 2001 the Sanger Institute began to sequence the zebrafish genome using
BAC libraries and shotgun sequencing. To date, approximately 1.41 GB of the
genome is sequenced with around 0.59 GB remaining (Sanger Institute). The current
gene-set is reported at 24,147 protein coding genes, 80 pseudogenes, and 6
retrotransposed gene predictions. The noncoding RNA genes such as ribosomal,
transfer, and micro RNAs have not been released to date.
The chromosomes of the zebrafish are all similar in size and appearance.
These physical characteristics inhibit the visual identification of the specific
chromosomes from one another. Thus, in 2003 the zebrafish community decided to
number the chromosomes not based on size as in other organisms but based on the
numbering of genetic linkage groups (LGs) (Sanger Institute). A linkage group is a
set of genes that are transmitted or inherited together on a given chromosome.
Karyotyping of the zebrafish has revealed 25 linkage groups (chromosomes) with
centromeres mostly located in the middle (metacentric) or near the middle
(submetacentric) of the chromosome (Amores et al. 1999, Schreeb et al. 1993). A
few linkage groups however, were found to have centromeres located near the ends
(acrocentric) of the chromosomes (Wallace et al. 2003).
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Genetic Maps
The genetic mapping of mutant loci can be performed by utilizing microsatellite
markers to scan the genome. Genome scanning with microsatellite markers is the
preferred technique owing to the minimal technical requirement and higher accuracy
(review Dahm et al. 2005). Markers can be designed to a specific gene or location on
a linkage group (chromosome). In zebrafish, the commonly used markers are called
Z-markers. These markers are comprised of CA repeats that were cloned and then
mapped to the 25 linkage groups. Using these markers one can link a mutant locus to
a linkage group based on recombination events. Once the linkage group has been
identified the recombination events for each marker will define the map distance
between the marker and the mutant locus.
There are four genetic maps (MGH, MS, MOP, and GAT) that have been
created for the zebrafish (review, Dahm et al., 2005). The meiotic Massachusetts
General Hospital, Boston (MGH) map is the preferred genetic reference map. This
map was created using a panel of 44 diploid F2 individuals (F1: India crossed to AB
strains) and 705 microsatellite markers (Z-markers) (Knapik, 1998). This map was
completed in 2001 and comprises 25 linkage groups with 3,845 Z-markers with
averaging interval spaces of 0.6 cM (Hubdard et al. 2009). The density of tightly
linked microsatellite markers becomes increasingly important as one tries to narrow
down the region containing a mutant locus in order to identify the affected gene.
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Mapping Panels
The first step in cloning the gene that harbors a mutation created from a
forward genetic screen requires finding the linkage group or chromosome on which
the mutant locus lies. The preferred method of mapping a mutant loci to a linkage
group is through the construction of a gynecological diploid (early pressure) mapping
panel derived from heterozygous mutant mothers. This method has several
advantages. First one can determine the relative location of the mutant locus in
relation to the centromere: if the mutant locus is close to the centromere the number
of mutants will be close to 50%, if the mutant locus is far from the centromere the
number of mutants will be less than 10%. Secondly, this method provides a large
target to link the mutant locus to a linkage group. Because all the embryos are
derived from the mother’s chromosomes and the mutant phenotype is only visible if it
is homozygous this tells you there are no crossover events between the mutant locus
and the centromere and hence this whole interval is mutant, a definite advantage. In
contrast, embryos that are phenotypically wildtype may be heterozygous or
homozygous wild-type and appear unlinked.
The next step is to further refine the location on the linkage group through
fine mapping so as to identify the precise location of the mutation. Here haploid
embryos can be powerful tools. One advantage to using haploid embryos is that the
phenotype is also the genotype as the recessive ogre mutation is not masked by the
dominant wild-type allele. For this reason both the wild-type and mutant embryos are
equally important. Another reason haploids are valuable is the number of mutant
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embryos in a haploid cross is twice that of a normal diploid cross and perhaps much
greater than that of a gynecological diploid (early pressure) cross. The downside to
this approach, however, is that haploid embryos have their own unique phenotype as
they are smaller, sometimes making identification of mutant and wild-type phenotype
difficult.
To utilize these gynocolgical mapping panels one must use a couple
techniques to create them. To produce a gynological diploid the second polar body is
prevented from exiting by applying high pressure a minute and a half after
fertilization, this results in a diploid embryo with only the mother’s genetic material
(Streisinger et al., 1981). The meiotic division of the eggs of most vertebrates arrests
in metaphase II. When fertilization of the egg occurs, the second polar body leaves
the egg and the haploid pronucleus of the egg then fuses with the pronucleus from the
sperm producing a diploid organism (review: Alberts et al., 2008). To produce
gynogenic haploid embryos, the sperm from the males are collected and irradiated
with UV light to render their genetic material impotent. The sperm, however, still are
able to activate cleavage in the eggs. With the loss of the second polar body
occurring upon fertilization and no viable genetic contribution from the sperm, a
gynogenic haploid embryo develops (Streisinger et al., 1981).

Microsatellite and Gene Mapping
Genetic mapping involves the visualization of polymorphisms using
molecular genetic markers. Of the many methods available to visualize
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polymorphisms in DNA fragments, the simple sequence length polymorphisms
(SSLP) is the most common and simplest method (Postlethwait et al., 1999). This
method relies on using markers that cover areas within the genome that vary in length
due to the addition or deletion of CA repeats (sometimes within the intron or 3’
untranslated region of a gene). In zebrafish, the most common microsatellite marker
is known as a Z-marker. These markers identify SSLP of CA repeats on the
Massachussettes General Hospital microsattelite map and have an average mapping
resolution of 0.6 cM (Knapik et al., 1998). In other cases, where a Z-marker is not
present, a gene may suffice. Genes like Grp1 that contain regions of GT repeats in
introns can be polymorphic between mutant and wild-type individuals. These
fragments are amplified by PCR and then separated by size on an agarose gel using
electrophoresis, then visualized with ethiduim bromide and UV light. If the marker is
polymorphic in the mutant and wild-type alleles, a band (or bands) of a certain size
will segregate with either allele. An example is shown in Fig. 16 A for a marker that
is very closely linked to the ogre locus. Here the mutant allele segregates as the
lower molecular weight band “d” while the wild-type allele segregates with the higher
“u”. A second example is shown using a gene that is also very closely linked to ogre.
(Fig. 16 B: Grp1). Here the size distribution of the amplified products are multiple
bands for both the wild-type and mutant embryos. However, only the mutant allele
segregates with the highest molecular weight band ”u” and only the wild-type allele
segregates the lowest molecular weight band “d”. If a recombination event were to
occur, a phenotypic wild-type embryo would have the size polymorphism of the
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mutant or vice versa. From these recombination events one can determine how far
away the mutant locus is from the marker as the higher the numbers of recombination
events the further the distance. The genetic distance is calculated by the equation:
N/T *100=distance in cM (N= total number of recombinant individuals, T= total
number of embryos tested with the marker).

z5141

wild-type

ogr

wild-type

ogr

Grp1
ogr

ogr
wild-type

wild-type

Figure 16. Linkage analysis of the ogre locus using microsatellite markers. Gel
electrophoresis of PCR-amplified products showing the two closest linked markers to
the ogre locus, the Z-marker z5141 and the gene Grp1 (Grp1).
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Candidate Gene Testing
Once the closest linked markers on both sides of the mutant locus have been
identified (hopefully within a small genetic interval) the Sanger map is searched to
identify all the potential genes of interest between the two markers. A literature
search for similar mutant phenotypes in other organisms as well as identification of
each gene’s protein function is used to select the candidate genes.
To narrow down the candidate genes two different approaches can be used.
The first requires sequencing genomic DNA. This involves designing primers for all
of the open reading frames and amplifying their products for sequencing from
individual mutant and wild-type embryos. This method can be laborious for each
candidate gene. A second approach is to construct cDNA from mutant and wild-type
embryos and sequence this. This is accomplished by isolating mRNA from a pool of
forty plus embryos of each phenotype and performing Reverse Transcriptase PCR
(RT-PCR) to generate cDNA. Primers are designed to cover the entire gene to
produce products for sequencing. This method is faster because fewer primers sets
are needed, however, PCR errors and the cDNA that is generated from a collection of
40+ embryos might possibly mask a recombinant. To validate RT-PCR results, new
primers are usually designed to the region spanning the potential mutation and
individual embryos’ genomes are sequenced.
Finally, once a candidate gene has been found to harbor a mutation the
expression pattern of its product is examined by in situ hybridization. Its temporal
and spatial pattern should bear some resemblance to the defects present in the mutant.
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Results
Initial Mapping of the Early Cell Cycle Arrest Mutant ogre
The initial mapping of ogre was performed by Donald A. Kane in the Postlethwait
laboratory at the University of Oregon used a gynecological diploid (early pressure)
mapping panel. He mapped ogre to linkage group 23, somewhere near the middle of
the chromosome arm.

Fine Mapping of ogre
Using these results I remapped the ogre mutant in more detail on linkage group
23. In summary, over 600 haploid embryos were generated to further refine the map
location of ogre. I used a total of six markers that spanned a 50 cM region on linkage
group 23. These markers included z31657, Grp1, z20492, z7890, z5141, and z9129,
two of which are shown in Figure 3.0. Each was tested on individual mutant and
wild-type embryos looking for the presence or absence of recombination events in an
effort to narrow the region between the initial linked Z-markers and the mutation. In
Figure 17 I show a small portion of my data (spread sheet) illustrating how these data
are presented. Recombinant portions of the chromosome are indicated in yellow.
While some markers have a high number of recombination events and others have a
low numbers of recombination events. In individual embryos, such as A3 and H3 the
same pattern of recombination occurs for several markers. Thus, not only was I able
to determine genetic distance, but I was also able to correctly order the markers
within the vicinity of ogre. My linkage analysis resulted in narrowing the original 50
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cM region to within 6.4 cM of Z-marker z31657 which had 36 recombinants out of
550 on one side of the ogre locus and 0.15 cM of Z-marker z5141, which had one
recombinant out of 645 embryos (H3) on the other side. These linkage data are
presented as a linkage map in Figure 18.

Figure 17. Mapping data used to further refine the position of the ogre locus on
linkage group 23. This figure shows only a portion of the microsatellite markers that
were used to fine map ogre on linkage group 23 and only a subset of the haploid
mapping panel. In the leftmost column are the recombination frequencies in percent
for each microsatellite marker (column A.4). Between these two columns are the
position of the marker on the MGH map in cM and its location on the Ensembl
Sanger sequencing project in Mb. The Z-markers are ordered by their recombination
frequency from the ogre locus (highlighted in blue) and their pattern of recombination
in individual haploid embryos (each represented by a single column). Columns that
are data from mutant embryos are highlighted in pink at the top of the column, and
indicated by “o” in the ogre locus row. Columns which are wildtype are not shaded
and are denoted by “w” in the ogre locus row. “u” corresponds to the upper band and
“d” to the lower band observed on the ethidium bromide stained gels. Yellow
highlighted boxes indicate recombination events.
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Figure 18. The location of the ogre locus on linkage group 23. The map was
constructed using the number of recombination events between the mutation and each
marker. The order of the markers was determined by looking at the recombination
events in individual haploid embryos as shown in Figure 3.1. For each marker, the
number of recombinant individuals followed by the number of total individuals tested
is listed on the left. On the right, the distance between markers (or between ogre) is
shown in cM.
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While my closest marker z5141 was 0.15 cM from the mutation, this Z-marker
was not located on the physical (Sanger) map. The closest markers I could find on
the Sanger map were z31657, located 6.43 cM away (33.9 Mb on the Sanger map),
and z20492 located 3.66 cM away on the other side of the ogre locus (40.1 Mb on the
Sanger map). From these markers I narrowed down the region on the Sanger map to
a 6.2Mb region in which to look for candidate genes.

Identification of Candidate Genes
One of the original candidate genes for ogre was RhoA. RhoA was a likely
candidate gene because of implications of its cellular phenotype in Drosophila. In the
Drosophila mutant pebble, ECT2 (an activator of RhoA) is non-functional and results
in defects in cytokinesis and large multinucleated cells (Hime and Saint, 1992;
Tatsumoto et al., 1999). RhoA, however, was quickly eliminated due to its lack of
linkage to ogre. Fortunately, other genes that directly interacted with RhoA or were
involved with cytokinesis were found in the interval defined by my recombination
analysis on linkage group 23. These now became the prime candidates.
The critical region of 6.2 Mb on linkage 23 containes 46 genes (Fig. 19). Out of
the 46 genes, five of these stood out (highlighted in green) because they are either
involved in cytoskeletal processes (cymb, Graspl/Grp1, and B6E521), or in
interactions with small G proteins known to be involved in cytokinesis
(LOC100003767PCR, and Racgap1).
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Figure 19. List of genes located within the 6.2 Mb critical region on linkage group 23
containing the ogre locus. Candidate genes are highlighted in green. All of these
genes are either involved in cytoskeletal processes or known to be involved in
cytokinesis.
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To determine which of these five candidates was ogre I first tried to amplify open
reading frames (exons) from genomic DNA for sequencing. In certain cases where
the introns were small, I could amplify several exons at once with the same primer
pair. In the candidate gene encoding Graspl (Grp1) I designed a primer pair to an
intron that contained a large number of GT repeats. The product turned out to be
polymorphic in wildtype and mutant (Fig. 16). Further testing on 470 embryos of the
haploid panel revealed 10 recombinants allowing me to eliminate this candidate gene.
This also placed the ogre locus 1.45 cM away from Grp1 and within the vicinity of
another prime candidate gene, Racgap1.

Sequencing the Candidate Gene Racgap1
To determine if ogre was harboring a mutation in Racgap1, I designed
oligionucleotide primer pairs for PCR amplification of genomic DNA encoding all
17, exons including the 5’ and 3’ UTR regions. The amplified products were then
sent off for sequencing at the University of Michigan DNA Sequencing core.
Difficulties, however, were encountered because many of the primers would not
amplify some of the exons in the Racgap1 gene. Part of the difficulty was likely due
to the small exon size embedded in large intronic regions. Variations within the
intronic regions between the mutant and wild-type strains and the strains used to
generate the Sanger sequence would compound this issue.
Therefore with the help of Dr. Warga, we tried a different approach: Reverse
Transcriptase-PCR (RT-PCR). Reverse primers for the 3’ end of the Racgap1 gene
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were designed to produce cDNA from a collection of thirty-sixty embryos (sorted
based on phenotype). This cDNA was then used to generate three overlapping PCR
products that could be used for sequencing. From this approach we discovered a
transversion at base 1173 which changed a T into an A (Fig. 20). This resulted in a
cysteine residue becoming a stop causing a premature termination in exon 10. To
confirm these results, I sequenced the area surrounding this mutation in six ogre
mutants and four wild-type individuals bearing the closest recombination events to
ogre. All of the sequenced mutants contained the T to A transversion at base pair
1173 while none of the sequenced wild-type individuals contained this change in
sequence.

Figure 20. Sequencing of the Racgap1 gene reveals a mutation in ogre mutants. A)
Chromatographs of genomic DNA derived from the closest ogre locus recombinants.
Left chromatograph is wild-type, right chromatograph is mutant. In the mutant a T is
changed to an A (peaks highlighted in violet) at 1173bp causing a stop codon (star)
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instead of a cysteine residue. B) Illustration of the Racgap1 protein domains. The
wild-type protein is above and the putative ogre mutant product is below. Black
arrow from chromatograph indicates the rough location of the point mutation in the
Dag-PE domain of Racgap1. The red arrow indicates the approximate location of the
mutation and truncation of the protein. The functional domains are color coded
(green= coiled coil, pink= low complexity (LC), purple= Dag-PE, magenta=
RhoGAP).

Expression of racgap1 mRNA in the Embryo
My mapping data links ogre to the vicinity of Racgap1 and sequencing of
Racgap1 reveals that the ogre allele harbors a point mutation in the gene resulting in a
premature stop codon in the open reading frame of exon 18. If the ogre mutation is
truly the result of a nonsense mutation in the Racgap1 gene the following criteria
should be met:
1) If Racgap1 is a cell cycle protein, wild-type racgap1 transcripts should be
present in the egg before zygotic transcription begins.
2) If Racgap1 is the cause of the ogre mutation then transcripts should be
expressed in tissues that are affected in the ogre mutant.
3) If there is a nonsense mutation in Racgap1 of ogre mutants then racgap1
mRNA transcripts might be present in lower amounts, as seen in other zebrafish
nonsense mutations (Kane et al., 2005; Rios et al., 2011). Due to these types of
transcripts being targeted for degradation through the process known as nonsensemediated mRNA decay (review Chang et al., 2007).
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To address these issues I obtained the wild-type racgap1 cDNA clone from
OpenBiosystems and used this to generate sense and antisense dioxygenin (DIG)
labeled mRNA riboprobes for in situ hybridization (Fig. 21). First I looked at the 1cell to 4-cell stage to determine if racgap1 is maternally supplied. My results showed
that this is indeed the case. Embryos that were labeled with the anti-sense DIG
racgap1 probe, showed a very strong signal (dark purple color) demonstrating the
presence of maternal transcripts in all cells at this time (Fig. 21 A), whereas in
embryos that were labeled with the sense DIG racgap1 probe (the negative control)
had no signal, as expected (Fig. 21 B).
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Figure 21. The racgap1 antisense riboprobe detects mRNA present in the embryo.
The riboprobe, labeled with digoxigenin-UTP (DIG), is allowed to hybridize to the
endogenous mRNA. An antibody specific for DIG is used to detect the DIG-labeled
riboprobe. The anti-DIG antibody, which is conjugated to the enzyme alkaline
phosphatase (AP), is visualized by a chromogenic reaction using the AP substrates
tetrazolium salt (NBT) and 5-bromo- 4-chloro- 3-idolyl-phosphate (BCIP). This
results in a purple precipitate forming in the cells that express racgap1 mRNA. A)
The control sense racgap1 riboprobe fails to hybridize to the racgap1 mRNA in the
2-cell embryo, the anti-DIG antibody does not bind and no labeling occurs. B) The
experiment anti-sense racgap1 ribobrobe anneals to the racgap1 mRNA in the 2-cell
embryo, the anti-DIG antibody binds to the riboprobe and a strong chromogenic
reaction is produced. Together A and B demonstrate that the signal is real specific.
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Next I looked at later stages of development after zygotic transcription begins.
This was to determine if racgap1 expression correlated with tissues that are affected
by the ogre mutation. I found that up to the end of gastrulation, racgap1 was
ubiquitously expressed at high levels throughout the blastoderm (Fig. 22 A-C).
However, following the onset of somites formation, when organ formation occurs,
racgap1 expression began to diminish in intensity in many locations. Thus, by the 18somites stage (18 hours), racgap1 mRNA was largely localized to the forming
nervous system, the intermediate cell mass (where red blood is produced) and to the
tail of normal embryos (Fig. 22 D). As I have demonstrated, each of these regions
undergoes considerable cell death in the mutant. Furthermore, cells exhibited either
high or low expression of racgap1 indicating that it is only produced when cells
require it for cytokinesis. Therefore it is likely that maternal stores are exhausted. At
24 hours of development, there was little change in racgap1 expression except that
now it was noticeably stronger in the brain relative to elsewhere (Fig. 22 F).
Finally I looked at racgap1 expression in the ogre mutant, to determine if it was
lower in abundance as would be the case with nonsense-mediated mRNA decay. Up
through gastrulation, it was not possible to distinguish mutant from wild-type.
However, by 18 hours, very little racgap1 expression was visible in the ogre mutant,
and then only in the nervous system (Fig. 22 F). By 24 hours, racgap1 expression
was no longer apparent (Fig. 22 G). From these results it is very likely that the gene
that I identified by mapping and sequencing is the correct candidate gene.
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Figure 22. Expression of racgap1 mRNA in the embryo at progressive stages in
development. In situ hybridizations were performed with the anti-sense digoxigenin
labeled racgap1 riboprobe. A) Two-cell stage embryo (as seen in Fig. 3.5) showing
maternal expression in all cells. B) 75% epiboly and (C) tailbud. racgap1 mRNA is
still present throughout the embryo. D and E) 18-somitess stage embryos. racgap1
expression is most prevalent in the nervous system, the presumptive erythrocytes and
the tail. In the mutant, levels of racgap1 expression have begun to decrease. F and
G) 26 hour old embryos. racgap1 expression is restricted to the nervous system, the
presumptive erythrocytes and the tail. racgap1 transcripts are no longer visible in the
mutant.
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Summary
Previously Dr. Kane had mapped the ogre mutation to linkage group 23. Using
the microsatellite markers located along linkage group 23 and a haploid mapping
panel I was able to narrow the ogre locus to a 6.2 cM interval/region on the Sanger
physical map, eliminating the candidate gene RhoA. Within this region, five
candidate genes were identified. One of the candidate genes, Grp1, was eliminated
quickly because its product for sequencing turned out to have a size polymorphism
that revealed multiple recombination events between Grp1 and ogre. The Grp1 gene
placed the ogre locus within 1.45 cM of Racgap1 and excluded all other candidate
genes. The subsequent sequencing of Racgap1 revealed a T to A transversion that
results in a stop mutation in exon 10. This would completely eliminate the RhoGAP
domain which is necessary for GAP function and thus cytokinesis. In situ
hybridization with racgap1 revealed that it was maternally supplied to the embryos
and that racgap1 is highly expressed in the regions where blood and nervous tissues
develop in wildtype embryos. The ogre mutants however, had decreased expression
of racgap1 by 18-somites indicating a nonsense mutation did exist in the Racgap1
gene in ogre mutants due to its degredation probably by the cells nonsense mediated
decay house keeping mechanism. Hence it is very likely that ogre is Racgap1. In the
next chapter I will test this idea by attempting to rescue the ogre mutation with wildtype racgap1 mRNA.
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CHAPTER IV
RESCUE OF THE OGRE PHENOTYPE
Background and Results
mRNA Rescue
In the previous section I showed that ogre locus maps in the vicinity of the
Racgap1 locus and that in ogre mutants there is a nonsense mutation in exon 18 of
Racgap1. This mutation is predicted to cause premature termination and eliminate
function as a GAP protein which is an essential role of Racgap1 during cytokinesis.
Like all cell cycle genes, Racgap1 is maternally supplied to the embryo in the form of
mRNA (Riley, et al., 2011; Yabe, et al., 2009). In zebrafish, these maternal mRNA
stores are typically sufficient to get the embryo through the first fifteen cell cycles,
after which zygotic transcription becomes necessary (Kane and Kimmel, 1993). In
the case of ogre mutants, there should be half as many good copies of maternal
racgap1 transcripts and no good copies of zygotic racgap1 transcripts. To further
demonstrate that ogre is the result of a nonfunctional Racgap1 gene, I asked if I could
rescue normal cell division after cycle 15 and normal aspects of embryogenesis by
providing wild-type racgap1 mRNA to the ogre mutant embryo.
The most common method used in zebrafish to ‘rescue’ a mutation is to inject
synthetic mRNAs into the yolk cell of the embryo between the 1-cell to 8-cell stages
(Hammerschmidt et al., 1998). The additional copies of wild-type mRNA sometimes
completely bypass the necessity for zygotic transcription of the gene. For example,
one-eyed pinhead (Zang et al., 1998) at least extends the period of ‘normal’

66
development, resulting in a more wild-type phenotype and thus ‘rescuing’ the mutant
(Zhang et al., 2008). This provides evidence that the candidate gene has been
identified correctly (Raeker et al., 2009).
A caveat to the rescue technique is that while injecting in too little mRNA
produces no observable improvement, too much mRNA can be toxic to the embryo
(Holder et al., 1999). This toxicity can cause developmental delays, developmental
abnormalities or embryonic lethality. To fully rescue a mutant the amount of mRNA
transcripts needed is a function of the number of cells that require it and how long it
is necessary in the developmental process. Cell cycle genes such as Racgap1 and
Emi 1 (harpy) are highly regulated in the cell cycle and are necessary for every cell
division throughout all of the developmental stages. The amount of mRNA needed
for full rescue of these genes is high, and would most likely exceed the lethal
threshold for the embryo. Thus a full rescue of a cell cycle mutant is unlikely. Lesser
amounts of the mRNAs, below the lethal threshold, allow for a partial rescue to occur
resulting in an intermediate phenotype somewhere between that of the mutant and
wildtype (Zhang et al., 2008). In the case of partial rescue, assays to measure the
amount of rescue or shift back to the wild-type phenotype become necessary.
In chapter 2 of this thesis I characterized the morphological and cellular
phenotypes of ogre mutants. Here I use gross morphological appearance, an embryo
movement assay, number of delta A-positive neural cells, and number of nuclei per
cell to demonstrate that wild-type racgap1 mRNA partially rescues the ogre mutant
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phenotype. These experiments strongly support my hypothesis that the ogre mutation
lies in the Racgap1 locus.

Results
To test my hypothesis that ogre is a result of a defect in Racgap1, I wanted to
rescue the phenotype by adding back wild-type racgap1 mRNA. To do this I
synthesized sense capped mRNA using wild-type Racgap1 cDNA (OpenBiosystems)
as a template, and injected it into embryos derived from heterozygous ogre mothers
(Fig. 23). Because injecting mRNAs is a complicated balancing act, as mentioned
above, I first performed an mRNA concentration series to find the maximum amount
of racgap1 mRNA I could inject without causing embryonic lethality. In subsequent
experiments, to control for developmental delays caused by the introduced mRNA or
false rescue results, I injected kaede mRNA into a portion of the embryos that did not
receive racgap1 mRNA. Kaede is a protein found in stony coral that fluoresces green
when exposed to UV light (Ando et al., 2002). The kaede mRNA injected embryos
had the same developmental delays as the racgap1 mRNA injected embryos but did
not rescue the ogre mutant phenotype.
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Figure 23. The strategy for racgap1 mRNA rescue. The plasmid containing the
Racgap1 cDNA was cut at end of the gene by the restriction endonuclease Xho1. The
linearized template DNA was then purified by PCR spin column (Qiagen). Sensestrand capped mRNA was synthesized using the SP6 mMESSAGE mMACHINE
system (Ambion) following the manufacturer’s instructions. The sense mRNA was
diluted in distilled water to 50 ng/ul, and microinjected into the yolk cell of 1- to 8cell stage embryos at a final concentration of 5 ng/ul.
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Rescue of Morphology and Optical Transparency
To assay for rescue I first looked to see if ogre mutant embryos displayed a
more wild-type appearance after injection of racgap1. As I described in chapter 2,
the ogre mutant phenotype becomes evident by the 6-somites stage as a visible loss of
optical transparency in the nervous system, which I have shown is likely due to
increased cell death. While there were no apparent differences in the mutant
phenotype at the 6-somites stage between the non-injected and kaede mRNA injected
control embryos, embryos that received racgap1 mRNA showed increased optical
transparency, thus appearing more wild-type in appearance. By the 9-somites stage,
1.5 hours later, there was still a significant improvement in the mutant phenotype of
embryos that received racgap1 mRNA when compared to embryos that received
kaede mRNA or nothing. racgap1 mRNA injected ogre mutant embryos retained
most of the identifiable head structures such as the ears and eyes. The shape of the
brain was more normal and the embryos were more optically transparent than the
control ogre mutant embryos (Fig. 24). At 26 hours, racgap1 injected embryos had
longer tails than control mutants, and while the phenotype was starting to degenerate
to that more typical of ogre mutants, there were still identifiable eye and head
structures, unlike the kaede and un-injected ogre mutant controls (Fig. 24).
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Figure 24. racgap1 mRNA but not kaede mRNA rescues aspects of the ogre mutant
phenotype. Embryos were injected at the 1- to 8-cell stage with either racgap1
mRNA or with kaede mRNA. The kaede injected embryos appeared no different
from the un-injected sibling embryos, apart from a developmental delay due to the
injection of mRNA. All embryos are oriented in left side view, dorsal up. A-C) 10somites stage embryos. Wild-type embryos (A) have visible morphological features
these are absent in the kaede injected mutants (B). Notably the racgap1 injected
mutants (C) look almost wild-type in appearance and are significantly more optically
transparent. D-F) 26 hour old embryos. While wild-type embryos (D) have a
developed brain and nervous system, the kaede injected mutants (E) lack these
features. In contrast, the racgap1 injected mutants (F) retain some brain structures
and have a more elongated tail.
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In summary, in these experiments the kaede mRNA injected embryos
displayed all the normal characteristics of the ogre mutant phenotype by the 6somites stage, while racgap1 mRNA injected embryos did not. It was not until the 9somites stage or later, that racgap1 mRNA injected embryos display loss of optical
transparency in the nervous system characteristic of the ogre mutant. Thus wild-type
racgap1 mRNA appears to be slowing the onset of the ogre mutant phenotype.

Rescue of Motility
A remarkable feature of these racgap1 injected ‘rescued’ embryos was that
they regained higher levels of tail motion that resembled the range of movement as
well as the ability to move the tail from side to side that is observed in wildtype (Fig.
25 A). This is in striking contrast to the normally paralyzed or rarely twitching tail
motions seen in the ogre mutant controls. I quantified this increased motility by
counting the number of tail wiggles occurring over a two minute interval (Fig. 25 BC). Although the range of tail motion observed in the racgap1 mRNA injected
embryos was comparable to wildtype, the number of movements was significantly
lower. Nevertheless compared to those of the kaede mRNA injected and un-injected
embryos, the number of movements was strikingly higher (Fig. 25 B-C). Once again
injection of racgap1 mRNA resulted in an improved phenotype that was intermediate
between that of ogre mutant and wild-type embryos. This increase in ogre mutant
motility is also intriguing in terms of the nervous system as it indicates that wild-type
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racgap1 mRNA likely is rescuing enough cells in the nervous system to the point
where they can differentiate and form proper synapses.

Figure 25. racgap1 mRNA rescues the mutant motility defects. A) Frame by frame
comparison of a wildtype and mutant injected with racgap1 mRNA. The racgap1
injected ogre mutants shows a similar range of movement as the wildtype. B)
Movements per minute for individual ogre mutants. Embryos are from different
clutches. All the racgap1 injected mutants wiggle, whereas none of the kaede injected
ogre mutants do. In the un-injected category a few of the mutants show a small twitch
of the tail on one side of the body. C) The average number of movements per minute
for both mutant and wildtype. ogre mutants on average are significantly more motile
after receiving racgap1 mRNA even if they do not wiggle as much as wildtype.
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Rescue of Neural Progenitors
Together the above observations indicate that fewer cells are dying in the
nervous system of racgap1 mRNA injected ogre mutants. Therefore I asked if there
are more neural cells in the racgap1 rescued ogre mutants. Delta A is transiently
expressed in cells that have committed to a neural fate but have not quite
differentiated (Thisse et al., 2001). Normally their numbers increase over time.
However in ogre mutants their numbers decrease and can be easily counted by the 16somitess stage (Fig. 8).
Using the low numbers of delta A-positive cells in the mutant at 26 hours as a
baseline (usually never more than 5 cells) I determined if racgap1 mRNA rescues
neural fate in the ogre mutant. If rescue occurs in the racgap1 mRNA injected
embryos, delta A-positive cell numbers should increase.
I found that the number of delta A-positive cells varies slightly by clutch,
presumably due to how much and how quickly maternal mRNA stores are exhausted.
For this reason I only compared the number of delta A-positive cells in racgap1
mRNA injected embryos to their siblings which had either been injected with kaede
mRNA or were left un-injected. Within a single clutch, the numbers of delta Apositive cells in the racgap1 mRNA injected mutants were significantly greater than
found in the un-injected or kaede mRNA injected mutants (Fig. 26, 27).
Nevertheless, these gains in cell numbers were in no terms near wildtype, as wildtype embryos averaged around 400 positive cells per embryo while racgap1 mRNA
injected mutants averaged about 20 cells per embryo. Nevertheless, this is still much
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greater than in the kaede mRNA injected mutants, which only averaged from three to
five cells. Thus, I do find a significant increase in the number of delta A-positive
cells in the racgap1 injected ogre mutants.

Figure 26. racgap1 mRNA rescues a portion of the delta A positive neurons. A-D)
delta A (dla) expression at 26 hours of development. All embryos are shown in left
side view. A, C) In wild-type embryos, delta A positive cells are so numerous they
are essentially uncountable. B) In kaede injected mutants, there are almost no
positive cells. D) In racgap1 injected mutants, a larger number of delta A-positive
neurons are detected.
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Figure 27. Increase in delta A-positive cell in racgap1 injected ogre mutants. A-C)
The number of delta A-positive neurons in mutants that were either racgap1 injected,
kaede injected or un-injected. A) Individual from different clutches (grouped within
their respective clutches). B) The average number of delta A-positive cells per
clutch. racgap1 injected individuals have significantly more delta A-positive cells
than kaede or un-injected siblings. (C) The combined clutch average for the different
mutant categories. On average, the racgap1 injected category has significantly more
cells.
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One caveat to this assay is that the mutant embryos are old and the effects of
the injected racgap1 mRNA have already begun to fade, as evidenced by my ability
to identify mutants easily based solely on morphology. Perhaps if I had done the
delta A assay earlier (e.g. at the 13-somites stage) the differences between the
racgap1 mRNA injected and control injected mutants would have been greater.
However, there are too many positive cells at this time to count accurately. An
alternative approach would be to find another probe that labels only a small subset of
differentiating neurons, although very few exist prior to the 13-somites stage.
Nonetheless these results, along with the previous morphological and motility
observations, indicate that a partial rescue in the nervous system is occurring in the
racgap1 mRNA injected mutants.

Rescue of the Multiple Nuclei Phenotype
As a final test I asked if there was a change in the cellular phenotype of the
racgap1 mRNA injected embryos. I selected the 10-somites stage to use the
collagenase assay because my previous work showed that cells in ogre mutants now
often contained two and four nuclei. I collected embryos at this stage in which the
racgap1 mRNA injected ogre mutants are morphologically indistinguishable from
their wild-type siblings. Like the previous experiment, racgap1 mRNA injected
embryos were assayed and compared to their kaede mRNA injected siblings. If ogre
mutants are rescued by wild-type racgap1 mRNA, the numbers of multinucleated
cells should decrease.
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I found that there was a significant shift in the cellular phenotype for mutants
that were injected with racgap1 mRNA when compared to mutants that were injected
with kaede mRNA (Fig. 28). In the racgap1 mRNA injected mutants, fewer cells
were observed with quad and double nuclei whereas more cells contained a single
nucleus. These results indicate that cytokinesis must be in part ‘rescued’ for the cell
cycles following cycle 15 (Fig. 28). Thus, the cellular phenotype of the racgap1
mRNA injected individuals appears more like that of the wildtype and less like that of
the kaede mRNA injected mutant.
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Figure 28. racgap1 mRNA rescues the ogre mutant nuclear phenotype. Embryos
were injected with racgap1 mRNA, and then at the 10-somites stage, individual
embryos were dissociated and viewed at high magnification as described in chapter 2.
(A) The percent of cells with multiple nuclei per individual embryo. Individual ogre
mutants injected with kaede (ogre 1-5) followed by racgap1 injected mutants
(racgap1 ogre 1-9 were plotted in comparison to individual wild-type siblings
injected with racgap1 mRNA. The racgap1 injected mutants showed a significant
shift from the percentage of multinucleated cells to cells with a single nucleus. (B)
The average percent of cells with multiple nuclei per group.
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Summary
In this chapter I have shown that providing exogenous wild-type racgap1
mRNA to the ogre mutant early in development partially ‘rescues’ many of its
characteristic defects shifting them towards a more wild-type state. Morphologically
the racgap1 injected mutants were indistinguishable from wild-type until at least the
10-somites stage compared to the control ogre mutants identifiable by 4-somites.
Unexpectedly motility in the racgap1 injected ogre mutants was rescued, with
movements similar to wild-type, however fewer. This rescue of motility was also
accompanied by more delta A positive cells in the racgap1 injected mutants. These
undifferentiated but committed neurons indicate a rescue of the neural progenitor
population. The cellular phenotype of the racgap1 injected mutants was also
observed to be rescued as fewer multinucleated cells were observed. Although there
was not a complete rescue of the ogre mutant phenotypes there was partial rescue.
Because Racgap1 is a cell cycle gene which is required in all cells until they
differentiate and is under tight regulation by the cell cycle, I would not expect the
embryo to be completely rescued. However the significant improvements that I show
for individual phenotypes collectively indicate that my hypothesis is correct and that
ogre is the result of a mutation in Racgap1.
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CHAPTER V
DISCUSSION
Cell Death in ogre Mutants
The mutant ogre was isolated in the Tübingen screen for essential genes
required during early development (Haffter et. al., 1996). It was found to arrest in
early development and was later determined to have multinucleated cells due to a
block in cytokinesis (Kane et al., 1996). I have since found that the ogre mutant
phenotype is morphologically visible around the 6-somites stage at which time
mutants show a general loss of optical transparency, beginning in the head. Using
acridine orange staining, which is thought to distinguish apoptotic cells, I have also
shown that at the 4-somites stage, two hours prior to the morphological phenotype,
mutant embryos have atypically high numbers of dying cells in the brain. Notably,
this increase in acridine orange staining follows the block in cytokinesis as I show
that multinucleate cells begin to appear in the mutant at about the tailbud stage.
Altogether these data suggest that multiple nuclei and/or failed cell division can lead
to cell death, likely by apoptosis, and that this accounts for the lack of optical
transparency. This appears to be tissue specific as the loss of optical transparency
remains confined to the head and spine of ogre mutants, suggesting that the nervous
system is particularly sensitive to multinucleate cells.
One of the most interesting features resulting from the block in cytokinesis in
ogre mutants is that although all dividing cells undergo this fate, in some tissues cells
die while in others they are unaffected. This defined pattern of cell death resides
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predominantly in the central nervous system beginning around the 4-somites stage
and in the erythrocyte population happening between 18 to 26 hours of development.
It is well known that in Drosophila that asymmetric cell division is required in certain
neural populations and that in some of these cells asymmetric division results in one
cell that survives while the other is fated to die (Lundell et al., 2003; Karcavich, 2005;
Kumar et al., 2009; Orgogozo et al., 2002). Additionally in the rat, similar
asymmetric cell divisions have been identified in the nervous system that include cell
death (Shen et al., 2006). Blood, too, undergoes asymmetric cell division to produce
all the various cell types. In zebrafish, erythrocytes may act as the early stem cells as
their cell lineages produce some of the other early blood types such as neutrophils and
platelets (Warga et al., 2009). Thus, perhaps in such tissues where cells normally
undergo asymmetric cell division, which may or may not include programmed cell
death, failed cytokinesis is catastrophic and results ultimately in death.
Within the nervous tissues of ogre mutants we found through in situ
hybridization that many structures of the head are mostly absent while a few trunk
structures were able to develop. However, structures that form early such as the
presumptive dorsal sensory neurons were aberrant as axons appeared disorganized
and exhibited excessive branching. Although the dorsal sensory neurons that
differentiate early have abnormal growth and organization in ogre mutants, it is the
neurons that differentiate later that are most affected, as failure in cytokinesis results
in cell death. We hypothesize that this is due to differences in neuronal birthdays in
that the neurons which survive in ogre mutants have earlier birthdays.
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Our hypothesis that asymmetric cell division is necessary in certain neural
populations may also fit with the pronephric cell population where oriented cell
division has been found to be necessary for proper kidney formation (Williams et al.,
2011; Simons et al., 2009; Fischer et al., 2006; Hartelben et al., 2008). In ogre
mutants, where we have a block in cytokinesis, we would thus also have a failure
oriented cell division. The lack of podocyte formation in ogre mutants and the
presence of podocytes in another cell cycle mutant (harpy) that does not undergo cell
division indicate that the failure of oriented cell division results in no podocyte
formation.

ogre is Racgap1
The ogre locus was mapped to linkage group 23 by Dr. Kane (unpublished).
Through fine mapping I was able to locate the ogre locus within 1.5 cM of the
candidate gene Racgap1. By performing Reverse Transcriptase PCR of the racgap1
mRNA in ogre mutant embryos Dr. Warga was able to identify the ogre lesion, a T to
A transversion in exon 10. I confirmed this mutation by sequencing the six closest
ogre recombinants and the five closest wild-type recombinants; only the mutants had
the transversion.
The transversion in exon 10 results in a premature stop upstream of the GAP
domain. In Drosophila tumbleweed mutants, C. elegans cyk-4 mutants, and Hela
cells with GAP defective Racgap1 (MgcRacGAP), the abolishment of GAP function
prevents Racgap1 from inactivating RhoA, consequently there is incomplete furrow
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ingression, and cells fail to finish cytokinesis, resulting in multinucleated cells
(Sommers and Saint, 2003; Jantsch-Plunger et al., 2000, Hirose et al., 2001). We
observe the same cellular phenotype in ogre mutants as the cells that enter cytokinesis
never complete furrow ingression and become multinucleated (Kane et al., 1996).
The nonsense mutation indicated that racgap1 mRNAs should be targeted for
degradation through the nonsense mediated decay mechanism (Cheng et al., 2007).
Indeed with in situ hybridization of racgap1 we observed diminished expression in
ogre mutants by the 18-somites stage and complete elimination by 26 hours. Thus, it
is highly likely that GAP function is abolished in ogre mutants as well.
While the mapping and sequencing indicate that ogre locus is a mutation in
Racgap1, I tested this by asking if mutant embryos could be rescued by wild-type
Racgap1 function. If my hypothesis is correct, injecting wild-type racgap1 mRNA,
but not some other mRNA (like one that encodes the fluorescent protein Kaede),
should rescue the ogre mutant phenotype. I show that mutants injected with racgap1
mRNA had longer bodies and looked more wild-type including having increased
motility. Inspection with delta A staining revealed increased numbers of neuronal
progenitor cells at 25 hours, which likely explain the increase in motility. At the
cellular level I also found that racgap1 mRNA injected mutants had fewer nuclei per
cell (more wild-type like) than their un-injected siblings. No such morphological or
cytological rescue occurred when mutant embryos were injected with kaede mRNA.
Unfortunately, I was never able to completely rescue the ogre mutant
phenotype. This is to be expected as cell cycle mutants pose a challenge for a
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complete rescue as the high copy number of mRNA needed would be lethal (Zhang et
al., 2008). Another limit to this is the assays I used were designed for later
developmental time points, 10-somites-stage and 26 hours. Had I looked at earlier
stages I may have found greater ‘rescue’, but the motility and delta A assays could not
have been utilized. Time points earlier than 10-somites-stage would have also
required genotyping all individuals. Nonetheless, I was still able to demonstrate
significant improvements in morphology, motility, and cytology.

Summary
Sequencing of Racgap1 revealed a nonsense mutation in ogre mutants that
likely abolishes its GAP function and consequentially prevents the inactivation of
RhoA, a necessary step for the completion of cytokinesis. This failure in cytokinesis
drastically affects some neural, erythrocyte and podocyte populations, resulting in cell
death most likely by apoptosis. In contrast, in tissues such as the neural, erythrocyte
and podocytes, improper cell division may result in cell death. Further studies of
specific cell types and the number of nuclei as it equates to cell death could help to
identify key points in the mechanisms behind these cell fate decisions.
In conjunction with my mapping and sequencing data, further evidence for
ogre locus being Racgap1 lies in the reduction of racgap1 mRNAs at later stages of
development in the head and trunk of ogre mutants. Injection of wild-type racgap1
mRNA in ogre mutants resulted in a partial rescue of the morphological, neural, and
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cellular phenotypes shifting them to more wild-type. In summary, these data provide
definitive evidence that ogre is Racgap1 and indicate that just as in the fly, and the
worm, GAP function of Racgap1 is critical for the completion of cytokinesis in
zebrafish.
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CHAPTER VI
MATERIALS AND METHODS

Zebrafish Stocks and Embryo Maintenance
The ogre allele was isolated in a large scale mutagenesis screen (Haffter et al.,
1996) and maintained as described in Kane et al., 1996. Embryos were sorted, staged
during early cleavage, and incubated in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33
mM CaCl2 2H2O, 0.33 mM MgSO4 7H2O) (Mullins et al., 1994). Embryos were
incubated at 35 ˚C or 25˚C and allowed to develop to the appropriate stage.

Mapping of the ogre Locus
ogre was originally mapped to linkage group 23 by EP-diploid analysis by Dr.
Kane. Fine-resolution mapping was obtained by the generation of over 600 haploid
embryos and characterization of recombination frequencies between six SSLP
microsatellite markers.

Haploid Embryos for the Mapping Panel
To generate haploid embryos, sperm was collected from wild-type males,
placed into fresh Hank’s Buffer and UV irradiated for two minutes by placing them
approximately 4” below a flow hood UV light to inactivate the DNA. Irradiated
sperm was then used to fertilize eggs manually harvested from heterozygous ogre
mothers by first mixing the two together and then adding water, which activates the
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egg, thereby creating embryos that were 1N and derived from the maternal
chromosome which has a much higher rate of recombination (Streisinger et al., 1981).
Haploid embryos were allowed to develop until 24 hours, sorted based on mutant and
wild-type phenotypes and then dechorinated. Individual dechorinated embryos were
placed in separate wells of a 96 well plate containing 50 µl of PCR buffer (PCR
buffer + Tween+ NP40) and sealed with PCR tape. Plates were frozen at -20˚C to
break open membranes, incubated at 94˚C for 20 minutes brought to 55°C to digest
the embryo with 5 µl of proteinase K (PK) (10 mg/ml) for 60-90 minutes followed by
a twenty minute incubation at 94˚C to inactivate the PK. This crude DNA sample
was then diluted 1:20 before using for PCR reactions.

PCR
PCR was performed as per laboratory protocol. Briefly, reactions were set up
in 50 µl volumes with 5µl of sample (10-100 ng DNA), 0.2 µl Taq polymerase (10
units per µl), 200 µM dNTPs, 0.1-0.9 µM each of forward and reverse primers and
water added up to 50 µl. The primers and primer concentrations for the markers were
as follows:
Z31657: 900 uM of each primer, annealing temp of 55˚C, 40 cycles.
Z5141: 400 nM of each primer GGACAGTCTTGCCTGACAGCTG,
CAAGTGCTGCCATCAGCATACA, annealing temperature of 58˚C, 35 cycles.
Grp1: 500 uM of each primer CTGCAGAGTCAGGCAAGC,
ATCAGACCCTATAGTTTG, 55˚C, 35cycles.
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Z9129: F- CCATTGCAAAACAGTTTCCC, R- TGCTTGGACTTGTTTGAGCA, at
250 nM, annealing temp 58˚C, 35 cycles.
Z20492: 500 nM of each primer ATGAACAGTGTGCGAGATGC,
CTCGCAGACTTCAGATGCTG, annealing temp of 55˚C, 40 cycles.
Z7890: 400 nM of each primer TCACCGCCTTATTCTGTGAA,
CGAGAAAAGGGTAAAAATGCC, annealing temp of 58˚C, 35 cycles.
PCR cycle paramerters were as follows: 94˚C for 5 minutes, 94˚C for 1
minute, annealing temperature for 1 minute, polymerization for 1.5 minutes at 72˚C,
and extention of 7 minutes at 72˚C.

Reverse Transcriptase PCR (RT-PCR)
Thirty to sixty mutant or wild-type embryos were sorted based on phenotype
and placed into tubes. The medium was removed and replaced with 1 ml of Trizol
and vortexed till embryos dissolved. After a 5 minute incubation at room temp 200
µl of chloroform was added, vortexed for 30 seconds and incubated at room
temperature for five minutes. Tubes were centrifuged at 4000 rpm for 20 minutes at
4°C and the aqueous upper phase were removed and placed into an RNase free tube.
750 µl of isopropanol were added, mixed and incubated at room temperature for 10
minutes before centrifugation at 4000 rpm at 4°C for 20 minutes. Supernatants were
discarded and the pellets washed with 75% ethanol, re-centrifuged for 5 minutes at
4000 rpm to re-pellet, after which the ethanol was removed and the pellets air-dried
for 1.5 minutes. Finally, each pellet was re-suspended in RNase free water and its
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concentrations determined based on absorbency determined by the nano drop
spectrophotometer.
mRNAs were then used to generate cDNA according to laboratory protocol.
Briefly 0.5 µg of mRNA was added into a 10 µl reaction volume: 10 mM dNTPs (10
mM each), 0.3 µM of primer, volume brought up to 10 µl with the addition of RNase
free water. This was incubated at 65˚C for 30 minutes and then cooled to 4˚C. 10 µl
of MMLV Reverse Transcriptase mix was added (1 µl MMLV RT, 4 µl 5X first
strand buffer, 2 µl 0.1M DTT, 3 µl RNase free water) and incubated at 37˚C for 1
hour followed by 20 minutes at 70˚C. Once cDNAs were generated they were PCR
amplified using primers designed to the published Racgap1 coding sequence using a
55°C annealing temperature, 2 minute extension time for 35 cycles. After which
individual products were sent off to the University of Michigan DNA Sequencing
Core for sequencing.

Isolation of the ogre Mutation
Using primers designed from the published cDNA RT-PCR products
(described below) of mutant and wild-type embryos were generated and sequenced.
Primer racgap1011 was found to identify a nonsense mutation in exon 10 of the
Racgap1 gene that segregated with ogre. The mutation was confirmed by additional
sequencing of the six closest recombinant mutant and four closest of wild-type
individuals.
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Primers: Racgap2: GCAGGATTCTGAGAACGGG,
CAGGAGGACATGGAGACC, Racgap89: CACCGTGACTGTGCCTGC,
CATGCAGACGGACACCTCC, Racgap1011: ACTTAACATCTGCTGTGCTCT,
GCCTCTCTGCTCAATCTC, Rg15: GTTCTCAATGAAAGCATTGAG,
TTGCAGGATTCTGAGAACGG, Racgap25: CTGTAGTGAGTATGTTTGGTCCC,
CCATCGCTTTGGTTGTGATC, Racgap24: GAACGCCAATGTTCACACG,
GATTCAGTGACTGATGGAAGTGC, Racgap23:
CCTCACAGTGACATCATTAGCTC, CTGTAGCTCTGCTCCTGC, Racgap22:
GCCTTCCTCATCATCCATC, CATTACACAAGCATCTACACTAGC, Racgap21:
CTGCTAACCTTCCGCCTC, ATCTCCGAGCATGTAAAAAGGGC, Racgapl 20:
GACACGTCATACACACAGCAG, TGGAGAAATGCTAGTCAAAACAGG,
Racgap19: TCTTTATGGTGTCGGTTCGATTG, CCTTCACTGCGTCTACATTCC,
Racgap18: GTCTCTAACTCAATTCCTGGA, GCACAAGCTGCTGTATCATG,
Racgap17: TTGCCTCTCACAACGTCTTG, CCCGACTGGGAGAAAGTG,
Racgap16: GCAGAAGAGTCCCAGTCCTTC, CCTCCAGCACCAGAAATGC.

racgap1 Sense mRNA and Riboprobes
A plasmid containing the zebrafish Racgap1 gene was purchased from Open
Biosystems. From this antisense racgap1 mRNA riboprobe was produced by
linearizing the plasmid with EcoR1 and transcribing the DNA template with T7 RNA
polymerase; sense racgap1 mRNA riboprobe (and sense capped racgap1 mRNA)
was produced by linearizing the plasmid with Xho1 and transcribing the DNA
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template with SP6 RNA polymerase. RNA riboprobes were generated from
digoxyigen labeled RNA (Roche Applied Science) and sense capped mRNA
transcripts were generated using the mMessage mMachine SP6 kit (Ambion).

mRNA Rescue
Sense capped mRNA was diluted in distilled water to 50 ng/µl, and
microinjected into the yolk cell of 1- to 8-cell stage embryos at a final concentration
of 5 ng/µl. This concentration was the maximum amount of RNA that could be
injected without causing developmental abnormalities, but was enough for partial
rescue of the ogre mutant phenotype.

Whole Mount in situ Hybridizations
Whole mount in situ hybridizations were performed as specified in the Thisse
protocol (Thisse et al., 1993) with some slight modifications. Briefly, dechorinated
embryos were fixed for a minimum of eighteen hours in 4% paraformaldehyde in
Phosphate Buffer Solution (PBS) at 2-4˚C. They were washed once and placed in
100% methanol at -20˚C for a minimum of 48 hours. At the onset of the in situ
protocol, the embryos were rehydrated by gradually replacing the methanol with
PBST (phosphate buffer solution with 0.1% Tween 20). Once rehydrated, they were
washed three times in PBST. Digestion of the embryos with proteinase K (PK) was
performed at a concentration of 2.5µg/ml in PBST (¼ strength of 10 µg/ml) and the
amount of time varied with age and whether they were wild-type or ogre mutants.
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Briefly, 31 to 36 hour old wild-type embryos were treated for 20 minutes while same
age ogre mutant embryos were treated for 8 to 10 minutes; 26 hour wild-types were
treated for 10 minutes, and ogre mutant embryos for 5 minutes; 18 to 20-somites
stage wild-type embryos were treated for 4 minutes and the ogre mutant embryos for
2 minutes; 15-16-somites stage wild-type for 3 minutes and the, ogre mutant embryos
for 1.5 minutes. For younger stages I used less concentrated PK. For the 10-somites
stage, I used a concentration of 1.25 µg/ml in PBST and wild-type embryos were
treated for 1.5 minutes and ogre mutant embryos for 45 seconds; for the 4-somites
stage, I used a concentration of 0.625 µg/ml in PBST and wild-type and mutant
embryos were digested for 1.5 minutes. After proteinase K treatments, embryos were
re-fixed in 4% paraformaldehyde gently rocking at room temp for 30 minutes. Next
embryos were washed four times in RNase free PBST for 10 minute intervals and
placed in 60% hybridization buffer containing tRNA and Heparin (Hyb+) and
incubated for a minimum of two hours in a 70˚C water bath. After Hyb+ was
removed and replaced with the desired anti-sense mRNA probe diluted in Hyb+ and
incubated at 70˚C for a minimum of 8 hours. Following incubation with the probe,
embryos were washed through subsequent dilutions of 60% hybridization buffer : 2X
SSC (100% Hyb, 3:1, 1:1, 1: 3, 100% 2X SSC) for 15 minutes followed by 2 by 30
minute washes with 0.2xSSC at 70˚C. These washes were followed by 10 minute
washes of 3:1, 1:1, 1:3 0.2xSSC: PBST and 100% PBST at room temperature. The
embryos were then blocked for a minimum of 2 hours in Blocking Solution (2% goat
serum 2 mg/ml of BSA in PBST). This was replaced with anti-DIG antibody diluted
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at a 1:5000 in Block and rocked at 2-4˚C overnight. Post incubation embryos were
washed 7 times for ten minutes in PBST, and 3 times for 5 minute in staining buffer
solution (100 mM Tris HCl pH 9.5, 50 mM MgCl2, 100 mM NaCl, O.1% Tween 20.)
Once the NBT and BCIP were added to the staining buffer embryos were rocked and
monitored until the desired level of staining intensity was achieved. The staining
reaction was stopped by STOP solution (PBS pH 5.5, 1 mM EDTA, 0.1% Tween 20)
and the embryos were cleared in 70% glycerol and stored at -20˚C.

BrdU Staining
Embryos were staged at the 1-16 cell stage, allowed to develop to the desired
stage and dechorinated and then injected with ~70 pMol of 10 mM BrdU into the
yolk cell. Embryos were left to develop for the desired time (15 minutes for tailbud
to 4-somitess, 30 for 6-somites to 20-somites, and 1 hour for 18-somites to 26 hour
embryos) after which they were fixed with 4% paraformaldehyde overnight at 4°C
before being placed in 100% methanol at -20°C for a minimum of 48 hours.
Embryos were permeabilized with proteinase K, re-fixed for 30 minutes and
incubated in 2N HCl plus 0.1% Triton X 100 for 1 hour in a 37°C water bath. This
step is absolutely critical to remove the histones and expose the BrdU labeled DNA to
the antibody. Embryos were then washed 3 times with PBST for 10 minutes and
blocked for a minimum of 30 minutes in Blocking Solution (2% goat serum, 2 mg/ml
BSA in PBST) before adding the mouse anti-BrdU antibody diluted 1:500 in Block.
Embryos were then rocked at 2-4˚C overnight. Once the primary antibody was
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removed embryos were washed 3 times in PBST for 10 minutes before adding a Cy3,
or FITC-labeled goat anti-mouse secondary antibody (diluted 1:200) and incubated
for a minimum of 2 hours at room temperature after which embryos were washed in
PBST as before and viewed under a fluorescent compound microscope with the
appropriate filter. Alternatively, I also used the ABC Vectastain kit to label BrdU.
After the primary antibody treatment and wash, embryos were incubated at room
temp with biotinylated anti-mouse antibody for 1 to 2 hours. Embryos were washed
and incubated with Vectastain ABC reagent for 30 minutes, washed and then
incubated with the peroxide substrate solution. Stain was allowed to develop to
desired intensity before washing off the substrate and stopping the reaction.

BrdU/In situ Staining
Embryos were first processed for in situ hybridization prior to primary
antibody addition followed by the BrdU protocol beginning at the 2N HCl treatment.
Then primary and secondary antibody staining were performed with anti-DIG and
anti-BrdU as per each protocol described above.

Acridine Orange Staining
Staged embryos were dechorinated and soaked in 5 µM acridine orange for 30
minutes. Embryos were then washed 3 times in E3 medium for 15 minutes each
before viewing under low magnification using the FITC filter set.
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Nuleation Assay
Collagenase was added to modified Holtfretter's Buffer (60 mM NaCl, 0.6
mM KCl, 0.9 mM CaCl, 5 mM HEPES pH 7.4) at a concentration that varied based
on the age of the embryo. For post-gastrulating embryos (12 hours or older) I used 20
mg/ml and for gastrulating embryos I used 7 mg/ml. Individual embryos were placed
in 1.5 ml eppendorf tubes with the appropriate concentration of collagenase in 25 µl
of buffer and incubated in a 37˚C water bath for 5 minutes for tailbud, 6 minutes for
4-somites, 7 minutes for 10-somites, and 8 minutes for 20-somites staged embryos.
Using a widened pippet tip embryos were gently pipetted to dissociate the embryo.
25 µl of Holtfretter’s buffer was then added to dilute the collagenase and the tubes
were centrifuged for twenty seconds to pellet the cells. The supernatant was removed
and the cells were resuspended in 20 µl with Holtfretter’s buffer. Five µl of 0.01%
DAPI in 4% fix (4% paraformaldehyde in PBS) were added to the cell slurry. This
slurry was then viewed on a hemocytometer at 100 x magnification with a DAPI filter
to count the number of DAPI stained nuclei per cell.

Motility Assay
Embryos that had been injected with racgap1 or kaede mRNA as well as noninjected embryos were allowed to develop to the 25 hour stage and then monitored
under low magnification for 2 minutes. For each individual embryo, the number of
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movements were counted and the frequency of movements per minute were
calculated by dividing the number of movements by two.

delta A Assay
Embryos that had been injected with racgap1 or kaede mRNA as well as noninjected embryos were fixed at 25 hours and stained with DIG riboprobes specific for
delta A following the in situ hybridization procedure (described above). Because
there are so many delta A-positive cells in the wild-type only the delta A-positive
cells were counted in the mutant at 40X magnification.
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